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Abstract
This thesis details a variety of methods to build a surrogate-driven
motion model from a cone-beam CT (CBCT) scan. The methods are
intended to form a key constituent of a tracked RT treatment system,
by providing a markerless means of tracking tumour and organs at
risk (OAR) positions in real-time. The beam can then be adjusted to
account for the respiratory motion of the tumour, whilst ensuring no
adverse e↵ects on the OAR from the adjustment in the beam.
An approach to describe an iterative method to markerlessly track
the lung tumour region is presented. A motion model is built of the
tumour region using the CBCT projections, which then gives tumour
position information during treatment. For simulated data, the mo-
tion model was able to reduce the mean L2-norm error from 4.1 to 1.0
mm, relative to the mean position. The model was used to account for
the motion of an object placed within a respiratory phantom. When
used to perform a motion compensated reconstruction (MCR), mea-
sured dimensions of this object agreed to within the voxel size (1 mm
cube) used for the reconstruction. The method was applied to 6 clini-
cal datasets. Improvements in edge contrast of the tumour were seen,
and compared to clinically-derived positions for the tumour centres,
the mean absolute errors in superior-inferior directions was reduced
to under 2.5 mm.
The model is then subsequently extended to monitor both tumour
and OAR regions during treatment. This extended approach uses
both the planning 4DCT and CBCT scans, focusing on the strengths
of each respective dataset. Results are presented on three simulated
and three clinical datasets. For the simulated data, maximal L2-norm
errors were reduced from 14.8 to 4.86 mm. Improvements in edge
contrast in the diaphragm and lung regions were seen in the MCR for
the clinical data.
A final approach to building a model of the entire patient is then
presented, utilising only the CBCT data. An optical-flow-based ap-
proach is taken, which is adapted to the unique nature of the CBCT
data via some interesting conceptualisations. Results on a simulated
case are presented, showing increased edge contrast in the MCR using
the fitted motion model. Mean L2-norm errors in the tumour region
were reduced from 4.2 to 2.6 mm.
Future work is discussed, with a variety of extensions to the methods
proposed. With further development, it is hoped that some of the
ideas detailed could be translated into the clinic and have a direct
impact on patient treatment.
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Chapter 1
Background
1.1 Lung cancer and strategies for its treatment
Lung cancer has been estimated to be the most common cancer in the world,
with the highest number of cases and deaths [21]. In 2008, 1.61 million new cases
were recorded, accounting for 12.7% of all new cancers. 1.38 million deaths were
also reported in the same year, accounting for 18.2% of total cancer deaths. Since
1980, there has been an increase in the proportion of lung cancer patients from
the developing world, from 30% to 55% in 2008. Lung cancer is associated with
a high fatality rate, with over 86% of those diagnosed dying of the disease.
The most common forms of cancer treatment are surgery, chemotherapy and
radiotherapy (RT). This thesis is concerned with gaining and using knowledge of
respiratory motion to improve treatment, and since RT treatments are the biggest
benefactor of this knowledge, RT-based treatment will be discussed further.
RT is the medical use of ionising radiation to treat cancer. The intention is to
build up a lethal exposure to X-rays on the cancerous region, causing irrepairable
damage to the cancer cells’ DNA. At the same time, it is essential to spare as
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much of the surrounding healthy tissue as possible. An X-ray beam delivers dose
throughout its path through the tissue, hence X-ray beams are delivered from a
variety of directions, overlapping where the greatest dose is desired. The X-ray
beam can also be collimated across its width to further improve the dose profile.
The delivery strategy is determined during planning. A series of CT scans
are taken, from which key regions are identified. They include the tumour region
(TR) and organs at risk (OAR). Given the clinically-specified radiation tolerances
of each organ of the OAR, the delivery strategy is optimised such that the dose on
the tumour region is maximised whilst that delivered to the OAR is minimised,
or at least kept below a clinically acceptable level. One issue where knowledge
of respiratory motion can be of use is with the definition of the TR. Ideally [71],
the TR would be formed from the clinical target volume (CTV), which includes
the gross tumour volume (GTV) delineated from the planning CT scans plus a
margin to account for microscopic spread. However, in practice, further margins
need to be added to statistically compensate for daily positioning errors and organ
motion, resulting in the planning target volume (PTV). There is growing evidence
emphasising the importance of these additional margins, with a variety of studies
showing that changes in patient anatomy and breathing pattern occur between
planning and treatment fractions [60, 54, 64, 65].
The introduction of Image-guided radiotherapy (IGRT) has allowed daily po-
sition errors to be reduced. An important technology facilitating IGRT has been
the incorporation of cone-beam CT (CBCT) onto the treatment gantry, allow-
ing scans immediately prior, and during, a fraction of treatment. See Figure
1.1 for a picture of a typical RT treatment beam with orthogonally mounted
CBCT scanner. As a result of IGRT, PTV margins can be substantially de-
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Figure 1.1: Image from Medical Physics website (www.medicalphysicsweb.org).
RT treatment beam (MV) with on-board CBCT scanner (kV). The CBCT scanner
is orthogonally mounted onto the gantry.
Figure 1.2: A typical treatment RT workflow.
creased (cm to mm), substantially reducing the volume of radiation prescribed
[5, 6, 70, 74, 73, 2, 13, 24]. This large decrease is due to margins being expressed
in one dimension, which has a cubic relationship to the volume, on which the dose
volume is related. For example [71], reducing a 2 to a 0.5 cm margin around a
spherical tumour of diameter 5 cm results in a decrease in the irradiated volume
of the surrounding organs from 316 to 48 cm3. Figure 1.2 shows a typical RT
workflow utilising an on-board CBCT scanner.
Methods to better shape the dose are essential to realise the benefits of a
better defined target region. Methods such as conformal radiotherapy (CRT)
allow the dose to be shaped to that defined at planning. Other approaches, such
as Intensity Modulated RT (IMRT) go beyond CRT by varying the intensity of
irradiation within a radiation field. IMRT is achieved in practice via multi-leaf
collimators (MLCs); a series of beam shaping blocks arranged in opposed pairs.
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Figure 1.3: Image from Varian website (www.varian.com). Visualisation of how
a multi-leaf collimator (MLC) shapes the treatment beam (highlighted yellow).
Two MLC-strategies include delivering IMRT statically (beam o↵ whilst MLCs
move to new shape) or dynamically (beam on throughout radiation field delivery,
with MLCs exposing areas requiring higher dose for a longer period, within the
field). Figure 1.3 shows a visualisation of how the MLCs shape the treatment
beam.
Other methods of delivering IMRT include helical tomotherapy [39, 40, 20],
Cyberknife [1] and volumetric modulated arc therapy (VMAT) [72, 53]. With
helical tomotherapy, the dose is delivered in rotational fashion on a ring-based
gantry, with the patient is slowly translated through the bore of the machine.
Cyberknife achieves accurate delivery of dose by mounting a LINAC on a car-
production robot, which allows a large number of narrow beams to accurately
build a dose distribution within the target volume. The robot allows for dextrous
beam positioning, delivering beams from a large number of angles and locations
around the patient. VMAT uses a similar set-up to SABR except the dose is
delivered in one continuous arc, with the MLCs dynamically shifting to deliver
the required dose distribution over the target region. Delivering the dose in this
manner, as opposed to a series of static fields, decreases the time taken to deliver
the dose from 8-12 minutes (SABR) to around 2 minutes.
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1.2 Accounting for respiratory motion
Faster treatment times and smaller margins are important drivers behind further
developments of next generation RT treatments. Accounting for respiratory mo-
tion can o↵er a promising way to provide further improvements in these areas.
Gated [34] and tracked [62, 59] treatments utilise knowledge of tumour position
throughout the fraction to treat either at specific parts of the respiratory cycle,
or throughout it, respectively. Margins added around the tumour due to res-
piratory motion can potentially be decreased from around 1 cm to a few mm
[59]. Due to a reduced treatment duty cycle, gated treatments will most likely
increase treatment times. Breath-hold techniques or equipment [41, 31, 55] may
reduce this impact, by allowing the patient to spend more time in the required
part of the breathing cycle. Given treatment throughout the duty cycle, tracked
treatments may o↵er the optimal combination of reduced margins and shorter
treatment time. For gated treatments, it is possible to choose a treatment win-
dow such that the tumour lies close to its average position. This makes planning
the treatment simpler. For tracked treatments, the patient may have a variety of
respiratory states, and simply moving the beam based on tumour position may
give rise to complications. For example, if the tumour is at an extremal state, the
organs at risk (OAR) may also be in one, hence simply moving the beam may also
expose the OAR to additional dose. Strict [7] limits are detailed for the maximum
dosages the OAR can be exposed to, and this unplanned exposure may result in
these limits being breached. During arc-therapy treatments, margins are added
to the tumour to account for the full seen respiratory motion during planning.
Additional margins are added to account for the expected variation of this mea-
5
surement. If the actual respiratory motion were known, this additional margin
could be removed, instead delivering the planned treatment at specific parts of
the duty cycle to ensure the tumour positions are within the limits of that seen
during planning.
A variety of techniques and modalities have been used to assess tumour mo-
tion and shape. Weekly 4DCT scans have been used to assess changes in tumour
motion and shape during treatment [10]. Tumour motion was found to vary
widely between patients, but could be up to centimetres in extent. The majority
of this motion occurs in the superior-inferior direction. These scans can be used
to modify treatment before each fraction of treatment and take inter-fraction
variation into account. However, giving additional CT scans has significant hos-
pital resource requirements, as a 4DCT scanner must be made available at each
treatment, followed by rapid processing of the scans by medical physicists and
clinicians immediately prior to the fraction. Given the extent of the additional
requirements, as well as the patient dose implications from the extra scans, it is
unlikely that prior 4DCT-based modifications to the plan will be a practical ap-
proach. CBCT is available immediately prior to each fraction of treatment, mak-
ing this modality a much more suitable candidate for monitoring inter-fraction
variations and adjusting treatment accordingly. 4D-CBCT reconstructions can be
made by binning projections according to their phase [66], which is calculated us-
ing a surrogate signal extracted directly from the projections. A 4D-CBCT scan
can replace a standard CBCT scan, and hence can be integrated into the clinical
workflow without the need for additional scans. 4D-CBCT is able to provide
an indication of tumour motion, but because each reconstruction is made from
a reduced number of projections, the quality of each reconstruction is limited.
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This could be improved with longer acquisitions, but would impact on treatment
times and delivered dose. Due to binning, it is also possible for 4D-CBCT to
underestimate [9] the true extent of tumour motion.
Given the current popularity of integrated CBCT scanners on RT treatment
equipment, approaches to measuring respiratory motion which utilise this modal-
ity have immediate access to actual patient datasets. Given the large number
of problems with the current clinical state-of-the-art, 4D-CBCT, there is clinical
interest in better approaches to determine respiratory motion. For CBCT-based
approaches which can o↵er improvements upon 4D-CBCT, there is the possibility
to make a meaningful impact in this area within a relatively short time-scale.
1.3 Overview of thesis
This thesis details a variety of methods to build a surrogate-driven motion model
from a CBCT scan. The methods are intended to form a key constituent of a
tracked RT treatment system, by providing a markerless means of tracking tumour
and OAR position in real-time. The beam can then be adjusted to account for
the respiratory motion of the tumour, whilst ensuring no adverse e↵ects on the
OARs from the adjustment in the beam.
Chapter 1 provides some background information on lung cancer and how
it is treated with RT-based treatments. Chapter 2 looks in more detail at how
accounting for respiratory motion can be advantagous in RT treatments. Rele-
vant literature, including some state-of-the-art methods to determine respiratory
motion during a CBCT scan are discussed.
Chapter 3 describes an iterative method to markerlessly track the lung tu-
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mour region. Parameters of a surrogate-driven motion model are fitted during
the CBCT scan. Simply by monitoring the surrogate signal during treatment,
the model can then be used to determine the tumour position during treatment.
The model is robust against many of the issues a↵ecting CBCT, which is of a rel-
atively poor quality, such as limited field-of-view and scatter. The model can also
account for complex variations in breathing, such as hysteresis and varying depth
and length of breathing cycle. With each iteration, the cost function which is opti-
mised has been structured in a manner whereby it can be optimised quickly, with
a unique, global minimum. With suitable improvements, this also means that the
approach should fit the model within a clinically useful timeframe. Results are
given on a phantom case, simulated patient case and six clinical datasets.
Chapter 4 builds upon this and extends the model to a fully deformable one.
With this approach, it is now possible to monitor both tumour and OAR re-
gions during treatment. This extended approach uses both the planning 4DCT
and CBCT scans, focusing on the strengths of each respective dataset. The high
quality planning 4DCT is used to describe how the various parts of the patient
anatomy deform relative to each other. The CBCT, taken immediately prior
to treatment, is used to understand the inter-fraction variations that have oc-
curred between planning and the day of treatment. Many of the benefits with
the tumour-only approach are retained, such as a cost function which can be op-
timised quickly, with the potential to fit the model fast enough to be of clinical
use. Results are presented on three simulated and three clinical datasets.
A di↵erent approach is taken in Chapter 5, which presents an approach to
building a fully deformable motion model, but exclusively from the CBCT. An
optical-flow-based approach is taken, which is adapted to the unique nature of
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the CBCT data via some novel conceptualisations. For this latest work, results
on a simulated case are presented.
Chapter 6 explores a variety of extensions to the approaches discussed in
earlier Chapters. Briefly, some of these include dividing the number of regions into
regions (e.g. lung and non-lung), each of which can have a di↵erent relationship to
the surrogate signal. Another interesting area to explore includes using the fully
deformable model to augment the constrained non-rigid motion model, especially
in areas of large inter-fraction variation. Connections between the motion models
used in each of these methods are discussed with this in mind.
It is hoped that this thesis can provide a contribution to the literature in this
field. With further development, the authors also hope that some of the ideas
detailed could be made clinically feasible and hence be used to improve patient
outcome.
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Chapter 2
Literature review
2.1 FDK-based reconstruction
The Feldkamp-Davis-Kress (FDK) reconstruction [19] algorithm is currently the
most popular method used in clinical CBCT scanners. Assuming that enough
projections have been taken, this reconstruction approach can provide reasonable
quality reconstructions faster than iterative approaches. With a low number of
projections, streaking and other artefacts are present in the reconstructed vol-
ume. Iterative approaches, although taking longer to produce a reconstruction,
may o↵er a better alternative in this situation. However, lack of projections will
not be an issue with actual patient data, as the CBCT aquisitions are designed for
use with an FDK reconstruction approach, hence will sample the patient volume
enough to achieve a reasonable reconstruction quality with this algorithm. There-
fore, although this is also compatible with iterative methods, given the speed of
the reconstruction and popularity with clinical scanners, FDK-based reconstruc-
tion will be used in the first instance.
The FDK reconstruction approach to CBCT can be visualised by considering
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Figure 2.1: Diagram of CBCT geometry, where the source is assumed to have
a circular orbit, around a fixed point on line SO in the plane of the axial fan.
Each projection has an associated projection angle  . Useful for the FDK-based
reconstruction approach, the geometry has been visualised in terms of tilted (o↵-
axis) fan-beams.
each imaging cone as a series of tilted fans. Each fan spreads from the source to
the edges of the planar detector, passing through the volume. Figure 2.1 shows
an illustration of the arrangement. Apart from the axial fan beam, all the others
are angled out of plane. The FDK approach approximates each angled fan by
pre-weighting the fan-beam formula.
The volume V (x, y, z) can be reconstructed as follows [42]:
1. Preweighting with
! (µ, ⌫) =
SOq
SO
2
+ µ2 + ⌫2
= cos   · cos, (2.1)
where µ and ⌫ are the detector coordinates,   is the fan angle and  the cone
angle (in the plane of the fan angle specified by  ).
2. Row-wise ramp filtering with 1D ramp filter h (µ):
p˜ ( , µ, ⌫) = (! (µ, ⌫) · p ( , µ, ⌫)) ⇤ h (µ) , (2.2)
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3. 3D back-projection according to:
V (x, y, z) =
Z 2⇡
0
U (x, y,  ) p˜ ( , µ (x, y,  ) , ⌫ (x, y, z,  )) d , (2.3)
where
U (x, y,  ) =
SO
2 
SO + x cos   + y sin  
 2 (2.4)
Note that this formulation is only exact in the midplane. For tilted fan angles,
incomplete Radon data is collected as the source trajectory is circular and does
not meet the su ciency condition for exact reconstruction, given by [63].
Describing equations (2.1,2.2,2.3,2.4) in words, each projection is back-projected
after pre-weighting and the application of a ramp filter. The pre-weighting term
can be thought of as the geometrical magnification caused by the CBCT geometry
(i.e. X-ray point source combined with flat panel detector). The ramp filter is
important to avoid severe resampling artefacts when moving from Cartesian sam-
pled projection (radon) space of the detector, to the Cartesian sampled patient
volume. This is due to the back-projection formula being descibed essentially in
cylindrical coordinates (the directions of x and y depend on the angle  ). The
back-projection maps the pixel values in the 2D projections onto a host of lines
connecting the centre of the pixels to the X-ray source position within the 3D
volume. The line is described using the Radon transform, specially modified for
CBCT geometry. For further detail, the interested reader is recommended to read
the original paper [19] and other good summaries of this approach, for example
[69]. The back-projections are then summed together and renormalised (divided
by the number of projections), producing the final reconstruction. This final step
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is also called accumulation.
2.2 FDK-based motion compensated reconstruc-
tion
In this work, we use a modified FDK-based reconstruction algorithm [57] to calcu-
late the motion free image, called the motion compensated reconstruction (MCR).
The FDK algorithm can be conveniently modified to perform motion compensa-
tion in the reconstruction. For a given motion estimate, each back-projection is
deformed with the inverse of the estimated motion, calculated from the motion
model. This results in all the back-projections being moved into the space of
the reference image (sn = s˙n = 0). Upon the final summation and renormali-
sation of the back-projections, the final reconstruction should show a reduction
in motion artefacts, assuming the motion estimate during the CBCT is accurate.
Figure 2.2 shows a single back-projection before and after motion correction, plus
the improvements in motion artefacts and edge contrast attainable with motion
correction.
For the work presented, an open-source CBCT reconstruction toolkit [56] is
used for FDK-reconstructions. The FDK reconstruction algorithm was modified
to perform motion compensation after each back-projection step. To give an
example of reconstruction time, for a volume of size 300x300x150 voxels, an MCR
can be determined (from around 350 projections) in under 3 minutes. If motion
correction were not necessary, a GPU-accelerated version is available, which can
produce a reconstruction in under 15 seconds.
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Figure 2.2: An example back-projection before (left) and after (right) application
of deformation field from motion model during reconstruction. An example slice of
resulting reconstructions using contributions from all back-projections are shown
in the bottom row. With suitable motion correction, a visible reduction in motion
artefacts can be seen with higher edge contrast around anatomical features.
2.3 Determining tumour and other respiratory-
correlated motion from a CBCT scan
Critical to delivering tracked RT treatment is knowledge of tumour position
throughout the fraction. The time taken for each individual projection (millisec-
onds) is such that they can be essentially regarded as free of motion blurring. If
the tumour can be identified in each projection, it is possible to estimate its likely
trajectory. Implanted markers are one way to easily identify tumour position via
thresholding, from which methods [52, 4] have been published to determine the
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Figure 2.3: From Poulsen et al. [52]. Probability-based estimation of tu-
mor trajectory from cone-beam CT projections. The tumor is projected into
imager points (u1, v1), (u2, v2), (u3, v3) for imaging angles a1, a2, a3. (a)
First, the Gaussian probability distribution that maximizes the total probabil-
ity P (u1, v1, a1) ⇥ P (u2, v2, a2) ⇥ P (u3, v3, a3) ⇥ · · ·. is determined by maximum
likelihood esti- mation (indicated by the gray ellipse). The lines represent the ray
lines from the focus point of the imager system to the projected tumor position
on the imager. The tumor is known to be located somewhere on these lines. (b)
Next, the tumor position along these lines (and thus the three-dimensional [3D]
position) is estimated for each projection as the mean position according to the
3D Gaussian, that is, the midpoint of the lines cross section with the gray ellipse
(indicated by 1, 2, 3).
likely average and complete trajectory during the scan. Poulsen et al. [52] use a
probabilistic appoach to determining the tumour position. A Gaussian distribu-
tion is fitted to a series of lines connecting the tumour and source positions during
the CBCT scan, such that the total probability is maximised (see Figure 2.3).
Given a new tumour position, the estimated 3D position will be the intersection
of a line connecting this tumour position in the projection to the source, and the
fitted Gaussian distribution. This approach does not take into account hystere-
sis e↵ects which may lead to errors for patients where the hysteresis variation is
large. In order to have real-time tumour position estimation, new projections will
be required continuously, increasing dose delivered to the patient during treat-
ment. For practical reasons, this continuous exposure is also likely to be from one
direction only (orthogonal to treatment beam) possibly introducing errors in the
direction parallel to the CBCT angle.
Becker et al. [4] determine an average position of the marker over the CBCT
according to phase. Each projection of the CBCT is binned according to phase.
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Figure 2.4: From Becker et al. [4]. (a) The average intersection of the back-
projected rays from a given phase represents the average 3D coordinate for the
marker at that phase. (b) The 3D coordinate for each image (R) is estimated as
the point along the backprojection ray closest to the average trajectory (Rave( )).
For each phase, lines connecting the marker in the projections to the source posi-
tion are then drawn, with the average position chosen to minimise the distances
to the lines. Over all phases, an average trajectory therefore results. To deter-
mine the specific path for the CBCT (rather than the average path), the point
on each line closest to its phase’s average position was chosen as the 3D position
for that particular projection. Figure 2.4 shows a visualisation of how the av-
erage and projection-specific positions are determined. Becker et al.’s approach
is retrospective hence can only be used to determine tumour motion throughout
the scan. Assumming that the average positions for each phase remain constant
throughout treatment, it may be possible to slightly extend the technique to allow
real-time monitoring. However, as with Poulsen et al. [52], it would require con-
tinuous X-ray projections from the CBCT (increasing the dose delivered to the
patient) and to be practical at a direction perpendicular to the treatment beam
(introducing errors when estimating where on the line to assume the tumour is).
By relating the marker position to an externally monitored surrogate, which
can be measured frequently and easily, continuous X-ray imaging can be avoided
throughout treatment. Given a surrogate synchronised with the acquisition, mo-
tion models Cho et al. [12] have built from this data and used to track marker
position (inferring tumour position) in real time. Parameters of a simple linear
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motion model are found via a least squares estimation approach. The parameters
were found via an iterative approach and manually set to 5 iterations. Although
mentioned that it can be extended to do so, the simple linear model detailed by
Cho et al. cannot account for hysteresis. By utilising a surrogate, it is possible to
easily take a new surrogate measurement and estimate the 3D tumour position
using the motion model. Interestingly, Cho et al. also discuss how to update the
model should the relationship between surrogate and tumour motion change, as
well as extending the method to other RT treatment machines (e.g. Cyberknife’s
dual X-ray setup).
Krauss et al. [32] compare four approaches to respiratory motion prediction
of a lung tumour, based linear regression, neural networks, kernel density esti-
mation and support vector regression. An implanted gold marker’s position is
assessed with stereoscopic x-ray flouroscopy. The 3D marker positions are then
fed into each of the approaches for motion prediction estimation. Based on a
training data-set, each of the approaches essentially provides an estimate of the
tumour position a set time after the last sample (the ‘look-ahead’ length), to
be used to position estimation. The sampling rate could also be varied, making
the approach applicable for di↵erent uses, such as real-time position management
systems (e.g. RPM system, Varian Medical, Palo Alto, CA, requiring a sampling
rate of around 30 Hz) or gantry mounted flat-panel imagers (sampling rate of
around 5 Hz). The authors report an accuracy loss of up to 60% for the kernel
density estimation and support vector regression approaches, on the patient level.
Neural network approaches reported a maximum accuracy loss of up to 40% and
linear regression reported the least accuracy loss of around 30%. On average these
errors reduced to 7% for kernel density estimation and support vector regression,
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6% for neural network and nearly 3% for linear regression. The authors conclude
that an appropriate choice of the patient independent parameters is supposedly
more important than the choice of actual prediction method itself.
The linear regression motion model approach in particular has been integrated
into both imaging and treatment applications. Fast et al. [18] integrated the
linear regression motion modelling approach directly into CBCT acquisition. A
motion model, using either implanted electro-magnetic markers or an external
surrogate as an indicator of tumour position, was used to modify the CBCT
acquisition timing such that all phases of the respiratory cycle are sampled with
a more even distribution. For traditional phase-based binning in 4D-CBCT, for
example, this allows improved reconstruction for phases which are traditionally
undersampled. Although demonstrating a useful application of tumour-oriented
motion models, this approach increases the time taken to acquire the scan; unless
a sacrifice in the number of reconstructed phases is made. Krauss et al. [33] also
used the linear regression approach to actively adapt the apeture of an multi-leaf
collimator to track a tumour undergoing respiratory motion. The approach is able
to account for motion perpendicular to the treatment beam, which the authors
argue features the directions usually having steep dose gradients.
However, Cho et al’s, and the methods presented by Krauss et al. all crucially
still rely on a marker to identify tumour position in each projection. Implantation
of markers, however, is a surgical procedure associated with a risk of pneumotho-
rax [23]. It is also possible for marker migration to occur [49]. Therefore methods
which do not rely on implanted markers are desirable.
Lewis et al. [36] proposed a markerless method to identify the tumour, using
simulated projections of the 4DCT planning scan. A region encompassing the tu-
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mour from every phase of the 4DCT planning scan is used to segment the tumour
regions. After a registration (rigid, bony-anatomy-based registration between
phase of the 4DCT and CBCT reconstruction), simulated CBCT projections are
then taken of every segmented tumour volume (one simulated CBCT will result
for each phase of the 4DCT) and saved as templates for comparison. Projections
of the actual CBCT are then compared to the simulated projections at the same
angle and the closest match used to determine the position of the tumour centre
in the actual projection. The position is determined via a 2D translation-only
registration between the two best-matching templates and the actual projection,
from which the final position is determined from a Gaussian-weighted average of
the two results. Figure 2.5 demonstrates this matching process. The tumour tra-
jectory is then calculated in a similar way to Becker et al. [4], by first determining
the average phase-based trajectory and then determining the CBCT-specific full
trajectory by determining the closest point on the line (from tumour in projection
to source position) to the average position (using the phase associated with the
projection). As the method does not use markers, there is more error in deter-
mining the tumour centres. The results inducing the most error in estimating the
average position for each phase were iteratively discarded until agreement was
within a pre-defined threshold. Figure 2.6 shows the additional errors when us-
ing a markerless method to determine the average phase-binned trajectory. In a
subsequent piece of work [35], Lewis et al. are able to use this average trajectory
to produce a motion compensated reconstruction of the tumour region.
The method by Lewis et al. [36] involves matching CBCT projections with
simulated projections of the 4DCT planning scan, the latter a modality with
di↵erent scatter, imaging energy and geometrical properties to CBCT. Changes
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Figure 2.5: From Lewis et al. [36]. A cone-beam projection (left) and generated
DRR [projection] (right) for one patient. The ROI [tumour region] is the brighter,
highlighted region.
Figure 2.6: From Lewis et al. [36]. Examples of phase-binned tracking results
for full exhalation (upper left) mid inhalation (upper right) full inhalation (lower
left) mid exhalation (lower right). Line segments connect the source position to
the position that the tumor appears at in the imager for each projection.
in tumour size and motion over the course of treatment are not accounted for
when using simulated projections of the 4DCT. Outlier rejection techniques were
also needed to mitigate the e↵ect of bad matches in projections where the tumour
is not visible, or where other high-intensity structures overlap the region to be
matched. Although the authors use the tumour motion information to deblur
the motion corrupted CBCT reconstruction, this benefit is just confined to the
tumour region. It would be more beneficial to have a deblurred reconstruction of
the entire patient if possible. As with the implanted marker methods not utilising
a motion model [52, 4], Becker et al.’s approach is retrospective and cannot be
used to determine tumour position in real-time without continous X-ray imaging
and modifications to the method.
Fassi et al. [17] also utilise a prior planning 4DCT scan to build a patient-
specific motion model of respiratory motion, which is then adjusted to the day of
treatment via a CBCT scan. Respiratory motion is represented via three param-
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eters: baseline, amplitude and phase. Registrations between di↵erent phases of
the 4DCT are initially used to build the model, relevant at the time of the 4DCT.
The model is then adjusted to the day of treatment. The CBCT is used to deter-
mine the baseline, or mean, tumour position. An external surrogate is then used
to monitor the respiratory state, which can be used to calculate amplitude and
phase during radiotherapy treatment. The approach was tested on seven patients.
The actual tumour centres were manually marked on 100-200 projections of the
CBCT scan and compared to that estimated from the motion model, obtaining a
median tracking accuracy of 1.5 mm in the vertical and horizontal directions on
the CBCT projections. Note that this approach was published after the tumour
modelling approach published by Martin et al. [28], which forms the basis of
Chapter 3 in this thesis.
Many of the cited approaches use a motion model of some form. It is worth
mentioning that this is by no means necessary to e↵ectively monitor tumour
position. Gendrin et al. [22] present an approach based on 2D/3D registration.
An intensity-based registration of simulated projections of a prior CT scan are
compared with the actual CBCT projections. An iterative optimisation yields
a rigid-body transformation from which tumour position could be calculated.
The method utilises a GPU to allow the registrations to occur in around 0.5
seconds, which allows near real-time determination of tumour position. However,
this approach will still need to take this latency into account. The approach was
tested on a simple respiratory phantom, and could follow the motion with a mean
RMS error of 2.6 mm. Due to the nature of the 2D/3D registration, the approach
cannot resolve tumour motion in the imaging beam axis. This was fixed in the
authors’ approach, which may contribute to errors. Indeed, utilising a motion
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model is one way to overcome this issue, as motion from other projections can
view the associated tumour displacement from a di↵erent perspective. However,
using a motion model will inevitably impose a relationship between the tumour
motion and some surrogate, which may not always be the case.
In addition to tumour position, knowing the location and motion of the OAR is
also desirable to help ensure that any dosimetric constraints are not violated when
tracking the tumour motion or modifying the plan in other ways. It is therefore
advantageous to have a whole-patient motion model to determine positions of
other key patient anatomy during treatment.
Rit et al. [57] use a series of registrations between the phases of the 4DCT
planning scan to generate a series of deformation vector fields (DVFs). After
choosing the mean position as the reference volume, the DVFs describe how to
deform the reference volume to match each of the phases of the 4DCT. Figure
2.7 shows how a point maps to the other phases after registration, using two
di↵erent reference locations. During treatment, a rigid shift is frequently made
to align the CBCT reconstruction with the planning scan. A rigid shift is used
clinically as it is only used to correct for the baseline shift of the tumour. This
shift was applied to the DVFs to move them into the space of the CBCT scan,
from which the motion seen during planning was assumed to be identical to that
seen during treatment. By applying this shift to the whole patient, it is possible
for incorrect alignment to occur. In addition, assuming that respiratory motion
remains identical between planning and treatment fraction is essentially ignoring
inter-fraction variations that have occurred, which may introduce further errors.
For each CBCT projection, the phase was calculated and used to determine the
estimated deformation to deform the patient state at the time of the projection
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Figure 2.7: From Rit et al. [57]. 2D illustration of the trajectory of one voxel
over the ten frames of the 4D planning CT image with (a) the fifth frame as a
reference and (b) the mean position as a reference.
to the reference position. Linear interpolation of the DVFs between the two
neighbouring phases was used if the phase lied between those calculated from the
4DCT. Although it can account for hysteresis e↵ects and seems consistent with
that assumed for the 4DCT, the phase-based motion model assumes that each
breath cycle is identical with the last. For patients exhibiting varying breath-
ing depths this model may not be allow suitable flexibility to describe the full
respiratory variations seen in these patients.
Li et al. [37] present an interesting approach to determine tumour position
directly from a single X-ray projection, based on a motion model built of the
entire patient. First each phase of the 4DCT planning scan is registered to a
reference phase, to obtain a set of DVFs. Principal component analysis is then
used to determine the main variations in the DVFs, with the three largest prin-
cipal components retained for the model. The DVFs are then moved from 4DCT
space to that of the CBCT via a rigid registration on the bony anatomy. A sum
of squared di↵erences-based cost function is used to match a projection of the
deformed reference image with the desired X-ray projection. Parameters varied
to determine the match are those to vary the magnitude of the PCA compo-
nents, and parameters to facilitate a linear approach to rescaling the intensities
(4DCT will often be of di↵erent intensity levels to that seen in the CBCT, hence
the intensities seen in the projections will be di↵erent). As with Rit et al. [57],
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using a rigid alignment based on registering bony anatomy risks misalignment,
hence may introduce errors. Beyond rescaling each principal component, the rigid
alignment also means that the inter-fraction variation that can be accounted for
is very restricted. Li et al. attempt to compensate for matching projections of
a volume of a di↵erent modality to the actual projections with a linear rescal-
ing. In practice, this relationship is non-linear, possibly leading to inaccuracies.
This approach can be used in nearly real-time, as the tumour position can be
calculated in under 0.5 seconds, but requires a new X-ray projection be taken.
Therefore for continual tumour monitoring, this approach will require continuous
X-ray projections, increasing the dose delivered to the patient.
Zeng et al. [75] builds a model of the respiratory motion from CBCT projec-
tion data. Parameters of a time-varying deformable model are optimised over,
improving similarity between simulated and CBCT projections. The cost function
included an aperiodicity penalty term, favouring similar deformations at the same
point in the breathing cycle, plus deviations from this based on spatio-temporal
motion smoothness. However, they do not relate the motion to a surrogate signal,
so the model is retrospective and cannot be used to estimate the exact motion
that occurs during treatment. Real-time monitoring of patient deformations is
not possible as an entire CBCT scan is first needed prior to the optimisation
scheme commencing. Due to the large number of parameters, it is both time con-
suming to fit the model and is susceptible to local minima, the latter therefore
not being representative of the true motion.
Zhang et al. [76] propose a method to build a motion model of the whole pa-
tient from 4D-CBCT scans of the thorax region. As a motion model is built, this
approach can be used to provide real-time estimates of the entire patient, based
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on a new surrogate measurement. A standard 4D-CBCT set of reconstructions
are produced, which are registered together. This generates a set of deformation
fields describing how to deform the reference image to match the reconstruction.
4D-CBCT reconstructions are of particularly low quality, hence registrations be-
tween each of the phases may introduce errors at this stage. Principal component
analysis is used to reduce the e↵ects of these errors. All but the first two principal
components are then disregarded. The model is then calibrated by determining
the components of a matrix such that the motion observed is best correlated with
the measured surrogate at each phase and that measured one-third of a respira-
tory cycle prior. Zhang et al. minimise an L2-norm-based distance measure to
determine the best correlation. This motion model can account for hysteresis and
variable depths of breath, but the choice of surrogate signal (dome of diaphragm
extracted from projections) may lead to errors, as extracting the surrogate from
projections may contain innaccuracies in the source-to-detector direction. As
an alternative to registrations between phases of the 4D-CBCT, Zhang et al.
also propose building the model from registrations between phases of respiratory-
correlated CT data. However, to move this to the day of treatment they propose
a rigid registration on the bony anatomy, which su↵ers from the same issues (in-
correct alignments and ignores inter-fraction variation) as that described with Rit
et al.’s approach.
Other authors have proposed methods of building a motion model from other
modalities, for example 4DCT and MRI.
Odille et al. [51] proposes an iterative scheme to determine parameters of a
motion model, updating the MCR with each iteration. The authors name this
method the Generalised Reconstruction of Inversely Coupled Systems (GRICS).
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GRICS consists of a generalised reconstruction and motion model optimisation
steps, which are iterated over using a multi-resolution approach. A linear motion
model is proposed parameterise the motion during the MRI scan. The approach
is applied to moving phantom and free breathing patient data. In both sets
of data, the MCRs showed improved contrast and less motion blurring. The
approach o↵ers a promising method to coping with respiratory motion during a
scan. However, it should be ensured that the motion model is physically realistic.
During the motion model optimisation step, Odille at al. optimise a cost-function
which minimises a quadratic error term, which attempts to make the updates
account for the current di↵erences between the actual scan (with full motion) and
estimated motion, and also an additional smoothness constraint. The smoothness
contraint on the parameters of the motion model. The smoothness contraint
used may not hold in regions where sliding motion occurs, such as between the
chest wall and lung. In its current form, the model takes over 40 minutes to fit
the model. The authors intend to reduce this dramatically, as the approach is
amenable to parallelisation.
Hinkle et al. [26], proposes a maximum a posteriori (MAP) algorithm for
tracking organ motion. The approach estimates reconstructions of the motion-
free image and deformations in the anatomy. A cost function describing the
log-data likelihood of observing the data is constructed, consisting of a motion-
free motion free image estimate and velocity field estimate. This likelihood is then
maximised to obtain the most likely velocity field and motion-free image, given the
parameterisation of the velocity field and method of image reconstruction. The
maximisation is done via a Euler-Lagrange method, which provides updates to
alternately apply to current estimate of the motion-free image and velocity field.
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These alternate updates are then repeated until convergence of the algorithm.
The method was applied to 4D respiratory-correlated CT (4D-RCCT) phantom
data, increasing the signal-to-noise ratio (SNR). A select (central) point animated
with the fitted velocity field also showed excellent correlation (0.9988) in the SI-
direction to the displacement of the respiratory signal from the 4D-RCCT. The
approach was also used on a single patient dataset, again showing an improvement
in SNR and reducing slice mismatch artefacts (compared to using a binning-based
4DCT approach to reconstruction). This approach is an interesting approach,
however the time taken to obtain convergence was not mentioned, and may be
clinically unrealistic. In addition, the approach has been applied on a slice-by-
slice basis, with the assumption that the motion occurring during the acquisition
of a single slice ( 0.5 s) is minimal. This assumption may not be completely
accurate, as within 0.5 s respiratory motion would be expected in various parts
of the breathing cycle. If this were to be applied to CBCT, a similar analogue to
motion free slabs is not present. One would have to extend the approach to deal
with the individual x-ray projections, which could be assumed to be motion free.
Ehrdhardt et al. [16] proposed an optical-flow-based approach to determining
respiratory motion during a cine-CT scan. To create a reconstruction at a desired
respiratory phase, a non-linear registration method is used to estimate the optical
flow between neighbouring respiratory phases. An interpolated image can then
be created. Each series of slices of the cine-CT had an associated respiratory
phase via monitoring of a surrogate. To account for hysteresis, the inhale and
exhale parts of the respiratory cycle were treated seperately. Gaussian smooth-
ing is performed to limit the possible di↵erences in magnitude and direction of
neighbouring velocity vectors. The method was applied to four lung cancer pa-
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tient datasets. More than 2500 slices were acquired per patient, taking around
10 minutes. A decrease in motion artefacts was seen in the reconstructions and
reconstructions at specific respiratory phases were possible, including visualising
a range of snapshots to better assess respiratory motion. However, the approach
currently requires an extended scan of the patient, possibly exposing them to ad-
ditional imaging dose. The authors mention that the approach is computationally
expensive, taking over 30 hours. With cine-CT slices, full 3D reconstructions are
available for a limited set of slices, allowing a volume to volume registration to
be performed. In attempting to move this technique to other modalities, there
may also be issues for data of di↵erent dimensionality. For example CBCT, one
is dealing with 2D X-ray projections, as opposed to 3D volumes.
Table 2.1 lists some of the methods described in a more easily comparable
manner.
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Chapter 3
Tumour-only motion model
The work presented in this chapter was initially inspired by Odille et al’s [51]
work in MRI. From these conceptual beginnings, I built up the mathematical
underpinnings and overall approach to building the motion model from CBCT
and surrogate data from scratch. A large proportion of my time was also spent
acquiring the data and performing data analysis. Important components of the
approach adapted from other authors include tumour enhancement in the CBCT
projections [43], the CBCT reconstruction package [56] and form of the motion
model [38]. This work has led to first author journal, conference and workshop
publications, detailed in chapter 7.
3.1 Introduction
The most critical region to monitor during the delivery of RT treatment is tumour
position. For clinical RT treatments (e.g. IGRT), this region is scanned for shifts
between fractions and corrected for if necessary. Even with cutting-edge tracked
treatment systems, such as Cyberknife, it is only the tumour region which is
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exclusively tracked during treatment. With this in mind, a logical starting point
would be a method to monitor tumour position throughout the fraction. With
just one region to track, one would hope the problem is simplified significantly.
However, due to the di culty of determining 3D tumour position in the CBCT
projections, it still remains a di cult challenge.
In this chapter, a method is derived to build a motion model of the tumour
region. The approach has multiple advantages over other methods, such as being
markerless, having minimal additional scanning requirements and not delivering
additional dose to the patient whilst monitoring tumour position. Apart from
importing the PTV (tumour region plus a margin) from the planning scan, the
model is exclusively built from a standard CBCT scan. As CBCT scans are taken
immediately prior to, and during, every fraction of treatment, the approach can
account for inter-fraction variations. The form of the motion model used can ac-
count for complex respiratory motion, such as hysteresis and variations in length
and depth of breathing cycle. Although complex motion can be modelled, only
an external indicator of the breathing state, a surrogate, needs to be monitored.
The motion model is related to this surrogate, so it is required that during model
building from a CBCT scan, a synchronised surrogate trace be available. Af-
ter building the model, only a new surrogate trace is needed to predict tumour
position throughout treatment.
What it intended is a completely markerless approach, where the surrogate is
continuously monitored and used to determine respiratory motion of the tumour
region. Many forms of surrogate can be used with this approach. In this work,
an optical-based stereo-camera system is used. The presented approach could
therefore be integrated into a larger system, which could determine tumour posi-
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tion based on a motion model built from a CBCT scan, plus additionally monitor
the patient continuously for large shifts in their position. If such a shift occured,
treatment could be stopped and the new positioning CBCT scan used to re-build
the motion model.
The proposed approach could be applicable to many of the available radiother-
apy systems with on-board CBCT. In the first instance, the proposed treatment
system could be a modified standard SABR or arc-therapy treatment system. The
main addition would be a method to acquire a surrogate signal during treatment,
which includes a method to synchronise this to the CBCT projections if required.
The additional cost of a surrogate is much less than buying a completely bespoke
system especially for tracked treatment. Therefore this approach may enable a
more cost-e↵ective way to achieve a tracked treatment capacity, via an upgrade of
existing equipment (as opposed to a complete replacement). After describing the
general method, results are presented on phantom, simulated and clinical data.
3.2 Methods
3.2.1 Modelling tumour motion
As it is only the tumour motion that is of interest, the motion model is confined
to a relatively small region of the patient. In this chapter, the motion of the
tumour is approximated as the motion of a solid, non-deforming mass. With
this approximation, a rigid translation-only motion model is able to capture the
required range of motion (hysteresis, variable depth and length of breathing cycle)
whilst keeping the smallest possible number of parameter to optimise.
During the CBCT scan, it is assumed that the tumour motion can be described
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by a series of translations, Fn, of a motion-free image of the tumour region,
Vref (x) : x 2 ⌦TR. ⌦TR is the tumour region, imaged during the CBCT scan
and n = 0, 1, ..., (N   1) is an index corresponding to the time of each of the N
projections. The transformed tumour region, Vn, is then:
Vn (x) = Vref (x+ Fn (x)) . (3.1)
The translation-only motion model can be expressed as:
Fn (x) = snµ1 + s˙nµ2. (3.2)
µ1 and µ2 are the motion model parameters, each being three-element vectors. sn
is the surrogate signal, which is a scalar quantity. s˙n is the temporal derivative of
sn. The motion model parameters determine the superior-inferior (SI), anterior-
posterior (AP) and left-right (LR) motion of the tumour region as the surrogate
varies. µ1 determines the contribution to the overall tumour region motion for
changes in sn. Similarly, µ2 determines the contribution for changes in s˙n.
The motion model presented in (3.2) has a contribution from sn and s˙n. Figure
3.1 shows an example patient respiratory trace, plus a variety of tumour trajec-
tories for various values of the motion model parameters. To briefly speculate
upon the physical justification for the repsiratory properties that the surrogate
signals are correlated to; imagine that sn is a spirometry signal. sn therefore
indicates the volume of air in the lungs and should correspond to the depth of
breathing. s˙n is then the airflow to the lungs, which gives an indication of the
which part of the breathing cycle the patient is in [38], for example inhale or
exhale. s˙n can therefore be used to measure the hysteresis e↵ect. Here, instead
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Figure 3.1: An example patient respiratory trace (S1) and temporal derivative
(S2), plus description of resulting trajectory from changes in the motion model
parameters, µ1 and µ2. ⇤ is a multiplication. As the figure is in 2D, only the SI
component of µ1 and AP component of µ2 are being varied, with the resulting
motion shown on a sagittal plane.
of using a spirometry signal, we use essentially the average height of the patient
chest above the treatment couch. This form of surrogate signal has been shown
[27] to correlate well to a spirometry signal. Chapter 3.2.3 describes how this
surrogate signal is acquired in more detail.
To fully fit the motion model, six parameters need to be found. This small
number of parameters should provide a good balance between modelling complex
aspects of respiratory motion and not over-fitting the CBCT data. As CBCT is
of a poor quality (reconstruction artefacts, limited field-of-view, scatter) a model
which can be robust to these problems is important.
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3.2.2 Updating the motion model
The motion model parameters are what determine the motion of the tumour
with the surrogate signal. In this approach, given an estimate of the motion
model parameters, a method is presented to update them based on comparison
with the actual motion seen in the CBCT projections. With an estimate of the
motion model parameters, Vn is now an animated tumour volume. By comparing
projections of a simulated CBCT of this animated tumour volume with the actual
CBCT projections, di↵erences seen can be described in terms of updates to the
parameters. For what follows, it is assumed that the motion-free tumour region,
Vref , is available.
Introducing an error term for each projection, "n:
pn = Pn (Vn + "n) (3.3)
where pn are the actual projections and Pn is the projection operator. If the
simulated projections are not too di↵erent from the actual projections, "n can be
rewritten using a first order Taylor expansion.
"n ⇡ rVn ·  Fn (3.4)
where  Fn is the first order correction to Fn to make the estimated projection
more like the actual projection. Substituting (3.4) into (3.3) and rearranging:
Rn ⇡ Pn (rVn ·  Fn) , (3.5)
where the residues Rn = pn Pn (Vn) is the actual minus the estimated projection,
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at time n. Using an SSD-like cost function, residues at all projection angles can
be incorporated into a single update of µ,  µ:
 µ = argmin
 µ
"X
n
X
pixels
(Rn   Pn (rVn ·  F ))2
#
(3.6)
Given a rigid translation-only motion model (3.2),  F can be re-expressed:
 F = sn µ1 + s˙n µ2. (3.7)
Substituting (3.7) into (3.6) and algebraically expanding (see Appendix A for a
detailed derivation), the cost function can be shown to simplify to the following
form:
 µ1,  µ2 = argmin
 µ1, µ2
"
6X
✓, =0
 ✓  
X
n
X
pixels
C✓C 
#
, (3.8)
where
 0 = 1; C0 = Rn;
 1 =  µ1,x; C1 =  snPn (rxVn) ;
 2 =  µ1,y; C2 =  snPn (ryVn) ;
 3 =  µ1,z; C3 =  snPn (rzVn) ;
 4 =  µ2,x; C4 =  s˙nPn (rxVn) ;
 5 =  µ2,y; C5 =  s˙nPn (ryVn) ;
 6 =  µ2,z; C6 =  s˙nPn (rzVn) .
(3.9)
rx, ry and rz are the partial derivatives in LR, AP and SI directions, respec-
tively. The sum over pixels occurs over all pixels in the projection. Because of the
highly constrained nature of the motion model used, further regularisation (for
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example Tikhonov regularisation [68]) associated with more complex deformation
motion models are not necessary. Note that the motion model parameter updates,
 ✓, have been moved outside of the sums over projection and pixel. This speeds
up optimisation considerably, as sums over C✓ need only be calculated once, and
not for every trial value of  ✓. The parameter space was searched for the min-
imum, giving the motion model parameter updates  µ. The cost function is of
a positive definite quadratic form, hence is convex. This global minimum can
be found quickly and simply. A BFGS Quasi-Newton method with a cubic line
search procedure [11] was used to search the parameter space.
After the updates are calculated, the motion model parameters can be up-
dated:
µnew = µ+  µ. (3.10)
As mentioned earlier, these updates rely on knowledge of the motion-free recon-
struction, Vref . Unfortunately, this is not available and must also be determined
in parallel with the fitting of the model model parameters. Described in 3.2.5, this
is done in an iterative manner, with a motion-free reconstruction being calculated
with a modified FDK reconstruction algorithm.
3.2.3 Align RT and extracting the surrogate signal
Align RT (Vision RT Limited, London, UK) was used to produce the surrogate
signals. Their bespoke equipment consists of 3 pods which are mounted on the
ceiling around the radiotherapy system. Each pod projects a speckled pattern on
the surface of the patient and images it from two camera angles. Each part of the
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pseudo-random, speckled pattern can be uniquely identified, and from two views,
each point’s 3D position can therefore be determined. Three pods are used to
account for the gantry occlusion that occers from certain views as it rotates.
The system produces 3D surfaces at a rate of approximately 15 Hz. Currently,
this frame rate is only available in the research implementation of their software.
The raw bitmap images (with the speckled pattern) need to be post-processed
after the treatment to produce the 3D surfaces. Although this is currently not
real-time, it could be made to be with appropriate resource applied, based on
prioritisation on o↵ering this feature to Vision RT’s customers.
Vision RT’s bespoke software was used to process the bitmap images. These
take into account the geometry of the pods, lighting conditions in the room and
desired resolution required from the surface. The surfaces are written in ”.obj”
format, which is easily read by other third party software. In this work, the
surfaces were then loaded into MatLab (MathWorks, Massachusetts, USA) to
produce the 1D surrogate trace from the 3D surfaces.
Surrogate traces were extracted from the skin surface data via the use of
a manually defined 5-point bounding box. The bounding boxes were manually
drawn for each CBCT acquisition. Figure 3.2 shows an example patient chest
surface with bounding box overlaid. The mean height of the surface above the
treatment couch, within the enclosed region, was then used as the respiratory
trace. The raw surrogate signal was then normalised (mean subtracted; divided
by standard deviation).
An X-ray detector (Black Cat Systems, Westminster, USA) was used to syn-
chronise the skin surface data with the CBCT projections. A simple program,
running on the Align RT host computer, sampled the photon count every 8ms.
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Figure 3.2: Example Vision RT surface with 5-point bounding box.
Peaks corresponding to individual projections were identified and the system clock
used to put projections and skin surfaces in the same time reference. Once in
same time reference, the surrogate and projections are now synchronised and can
be used for model building and MCRs.
3.2.4 Enhancing the tumour region in the CBCT projec-
tions
The motion model introduced above (3.2) is only valid for projections of the tu-
mour region. Therefore, prior to fitting a motion model to the data, the projec-
tions are first pre-processed to enhance the tumour region. Previously described
in [44], the tumour enhancement method attempts to improve tumour contrast
in the projections by subtracting anatomy outside the tumour region from the
projections.
A standard reconstruction is performed, from which the tumour region is de-
lineated. The tumour region is chosen such that it is su ciently large to include
all of the tumour’s motion. For this work, the tumour region used was based on
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the PTV from planning. A simple program was constructed in MatLab (Math-
Works, Massachusetts, USA), which allows the PTV to be imported and then
stretched in SI, AP and LR directions. Importing the PTV was done for conve-
nience, and could be drawn manually instead. A mask is created of the tumour
region and used to create two volumes. One is of the tumour region with voxels
outside set to the same intensity as air (0). The other is of non-tumour region
with the tumour region voxels set to zero. Simulated projections of both the
tumour region and the non-tumour region are generated using the same geome-
try as the real CBCT acquisition. The non-tumour region projections are then
subtracted from the original CBCT projections.
If the non-tumour anatomy was stationary during the CBCT acquisition, only
the tumour region would be left in the subtracted images (for an ideal reconstruc-
tion su↵ering from no artefacts or CBCT-related problems, such as incomplete
field of view). However, as the other anatomy is moving, artefacts are generally
present in the subtracted images. The e↵ect of these artefacts is minimised by
masking the projections according to the projected outer edges of the tumour re-
gion, giving the enhanced tumour projections. Figure 3.3 illustrates the tumour
enhancement procedure. Also shown are part of an example projection before,
during and after application of tumour enhancement.
3.2.5 Iterative approach
Given some estimate on the motion, the motion model updates could be accu-
rately determined if the motion-free image were known. However, to determine
the motion-free image one must already know the motion correction to apply
during calculation of the MCR, which would mean knowledge of the true motion.
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(a)
(b)
Figure 3.3: (a) Visualisation of tumour enhancement procedure. P are the origi-
nal projections. Q and R are projections of the non-tumour and tumour regions,
respectively. (b) Example projection after each stage of tumour enhancement pro-
cess. Original (P), original minus non-tumour region (P-Q) and tumour enhanced
(P-Q masked by R) projections, from left to right respectively.
In this work, this circular problem is solved with an iterative approach.
An MCR is first calculated assuming there is no motion (i.e. standard recon-
struction). The MCR is then set as the reference volume and the motion model
parameter updates calculated. Because the MCR will have motion-related arte-
facts present, the updates may not be completely accurate. However, some of the
motion would be expected to be recovered, resulting in parameter updates closer
to estimating the seen motion than the no motion assumption. Equation (3.10)
can then be used to update µ1 and µ2. The updated motion model is then used
to recalculate an improved MCR. This MCR is now set as the reference volume
and the procedure repeated until convergence conditions are met. For this work,
the algorithm was terminated if the maximum change in the motion, over the
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entire CBCT acquisition, was less than one voxel in SI, AP or LR directions. The
volumes all had 1 mm isotropic voxels.
3.3 Results
3.3.1 Phantom experiment
A modified Modus QUASAR (Modus Medical Devices, London, Canada) phan-
tom was used to test the algorithm on clinical phantom data. An Elekta Synergy
(Elekta, Crawley, UK), at Guy’s and St. Thomas’ Hospital (London, UK), was
used to image the phantom. Emulating current protocol, approximately 350 pro-
jections are taken with the gantry turning one complete rotation, at a frame-rate
of 5.5Hz.
Via a signal generator, parts of the phantom can be set to oscillate in two
orthogonal directions in a linearly related way. Initially, an approach was taken
which avoided the tumour enhancement technique. This was done to indepen-
dently test the general iterative approach and see if it had merit. An ‘M4’ metal
nut was attached to an ‘internal’ moving point in the phantom, moving in the
SI direction. An analogous patient situation could be a metal marker implanted
in the site of the tumour. An ‘external’ surface of the phantom was monitored
with Align RT, which was moving in the AP direction. As with the simulated
data, the surface data was converted into a surrogate signal to be used for fitting
the motion model. In this case, precise knowledge of the position of the metal
nut was known, as was the fact that a linear relationship existed between the SI
position of the metal nut and the AP position of the tracked surface (surrogate).
The phantom was placed upon the treatment couch, with the metal nut motion
42
(a) (b)
Figure 3.4: Example projection of phantom: (a) raw (with o↵set detector); (b)
thresholded and masked.
approximately about the centre of rotation of the CBCT scanner. The metal nut
was set to approximately a 4 second oscillation period.
For this example, it was possible to avoid using the tumour enhancement
method. Simple thresholding and masking steps were applied to the CBCT pro-
jections to extract only the parts of the images of the metal nut. Figure 3.4 shows
an example projection before and after application of these pre-processing steps.
After running the proposed approach on the CBCT data, the algorithm termi-
nated after 3 iterations. Improvements were seen in the edge contrast after each
iteration. Figure 3.5 shows slice from the reconstruction of the nut region along
with select edge profiles. Measurements of the nut were taken from the MCR, all
of which agreed with the actual dimensions to within 1 mm. As 1 mm3 voxels
were used for the reconstruction this is a reasonable agreement.
3.3.2 Simulated data
The approach was applied to simulated dataset, based on actual patient data.
This also included application of the tumour enhancement technique on the tu-
mour region of the patient volume. A CBCT acquisition was simulated using a de-
formable registration-based motion model built from real patient data [46, 45]. An
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end-exhale 4DCT volume was non-rigidly registered to a series of free-breathing
CT volumes (taken in cine-CT mode). Unlike 4DCT, this approach allows the
motion to be simulated for any surrogate signal value. The motion model uses
the surrogate signal value and its gradient, which ensured the simulated motion
included some complex features of respiratory motion, such as hysteresis and
breath-to-breath variations. An Align RT surrogate trace, synchronised with the
patient data, was used to animate the patient volume. A simplified CBCT ge-
ometry and projection angle sequence (of similar properties to the actual CBCT
system) were used. To approximate set-up prior to radiotherapy treatment, the
mean tumour position over the simulated acquisition was placed at the centre of
rotation of the simulated CBCT.
Relative to the time-weighted mean position of the tumour centre of mass, the
mean error was reduced from 4.1 to 1.0 mm, without and with motion correction
respectively. The maximum error was reduced from 16.5 to 4.6 mm. Figure 3.6
shows a lateral view through the tumour region before and after motion correc-
tions, as well as the ground truth. There appears to be sharper edge contrast of
the tumour region after motion compensation, which is also a closer representa-
tion of the ground truth. With each iteration, the reconstruction got noticeably
sharper. The greatest corrections to the motion occurred at the earliest itera-
tions. Parts of the anatomy not moving as the tumour does, such as the ribs,
appear more blurry. Five iterations were needed for convergence.
3.3.3 Clinical data
To determine whether the proposed approach can be of use in actual clinical treat-
ment, the method was tested on actual clinical data. Ethics approval was given
44
Table 3.1: Patient and tumour characteristics.
Patient ref. Histology Tumour location TNM
1 Squamous cell carcinoma Left upper lobe T1bN0M0
2 Squamous cell carcinoma Right lower lobe T1N0M0
3 Adenocarcinoma Right lower lobe T1bN0M0
to access a series of datasets of lung cancer patients undergoing RT treatment
at Guy’s and St. Thomas’ NHS Foundation Trust (GSTT). At GSTT, patients
are planned on a combination of free-breathing CT and 4DCT scans. Organs at
risk are delineated on the free-breathing CT by a clinician. The 4DCT scans,
together with the free-breathing CT scan, are used to define a target volume (the
internal target volume, or ITV) which encompasses the tumour at all breathing
phases. CBCT is used to confirm alignment of the tumour with the ITV prior to
each fraction of treatment. If the CBCT shows that a shift is required, another
CBCT will be acquired to confirm alignment after the shift. An Elekta Synergy
(Elekta Limited, Crawley, London, UK) treatment machine, with orthogonally
mounted CBCT scanner to the treatment beam, was used for CBCT scans. For
all CBCT scans, synchronous 3D skin surface data was acquired from Align RT,
synchronised to the CBCT and had a surrogate trace extracted via the method
described earlier.
Six SABR datasets, from three patients, were used. All the scans were “fast”
scans, acquiring almost 350 projections over approximately 1.5 minutes. For each
patient, two scans were used, corresponding to the first and second scans of a
fraction (i.e. before and after the patient has been shifted to correct for the
basline shifts in tumour position). See Table 3.1 for patient details and their
tumour characteristics.
Since the ground truth of the 3D tumour location at the time of each projection
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was not available, the tumour location was identified in a subset of projections
where the tumour was visible. To assist the clinician in identifying the tumour
location, a bespoke piece of software was made to allow the clinician to manually
align projections of the MCR with the tumour. To reduce the workload of the
clinician, every fifth projection was chosen for a reduced dataset (approximately
70 per scan). Errors were calculated as the 2D distance between the manually
identified tumour location and: 1) the projection of the machine isocentre (centre
of rotation of the CBCT), 2) the projection of the mean tumour position (as
determined from the model fitting), and 3) the projection of the model estimated
tumour location. Projections where the tumour was not visible could be skipped.
To make the errors more meaningful, the units were scaled from pixels on the
projections to mm at the isocentre (i.e. multiplied by pixel dimension and scaled
from projection to isocentre position). Errors are referred to as either in the SI
or transverse directions, corresponding to the vertical and horizontal directions
in the projections, respectively. Figure 3.7 shows a projection after a clinician
aligned projections of the MCR.
To understand the observer variation, the delineations were repeated a second
time by the clinician. The results of the repeated delineation are shown in Table
3.3. The mean absolute variation of the observer delineation was under 2 mm
in SI and transverse directions, with maxima of nearly 8 mm. The clinician was
unable to delineate the tumour to a good accuracy in approximately two thirds
of the provided projections, which were skipped. Reasons for this include the
poor quality of the projections, similarity of the tumour edges to the background
and high contrast anatomy passing behind the tumour. The majority of the
skipped projections were from a lateral view, meaning the transverse errors mostly
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correspond to left-right errors.
Averaged over all cases, the use of a motion model reduced mean absolute
errors to under 2.5 mm, in either SI or transverse directions. For each individual
case, all bar one of the mean absolute errors are within the maximum observer
absolute error for that case. The mean absolute error was only 0.21 mm larger
than the maximum observer variation for the exception. Maximum absolute
errors with motion model tracking are under 7.5 and 7 mm in the SI and transverse
directions, respectively. Fitting the motion model also provides an estimate of the
mean position of the tumour. Using the projected mean position produced mean
absolute errors of under 3.5 mm in either SI or transverse directions, averaged over
all cases. Excluding one scan (3A), where the patient inhaled sharply, maximum
absolute errors under 8.5 mm were seen with the projected mean position. For
the case with the sharp inhalation, a maximum absolute error of 22 mm was seen
in the SI direction. Motion model tracking reduced this maximum absolute error
to 7.5 mm. Convergence was achieved in under 5 iterations for all cases. Table
3.2 show the full results for the patients.
Figure 3.8 shows the apparent improvement in edge contrast of the tumour
region with motion correction. A clinician compared the MCR to the planning
scans and confirmed that the motion corrected images provided better visualisa-
tion of the tumour features (e.g. spicules) and nearby vessels.
3.4 Discussion and conclusions
Initial experiments on the phantom has shown that the method can be applied
to a clinical CBCT scanner. For phantom data, where the surrogate-driven mo-
47
Table 3.2: SI and transverse absolute errors, given in mm at the machine isocentre
(centre of CBCT rotation). SI absolute errors are displayed first, followed by
transverse errors. Mean and maximum absolute errors given, with maximum
absolute errors in brackets.
Scan Error relative Error relative Error with motion
ref. to isocentre to calculated mean model tracking
1A 2.03 (5.42), 2.88 (6.67) 1.58 (4.71), 2.20 (4.88) 1.61 (4.51), 2.20 (5.00)
1B 1.72 (3.96), 3.53 (7.92) 1.70 (3.77), 2.70 (6.51) 1.69 (3.88), 2.70 (6.61)
2A 3.60 (9.48), 1.56 (3.96) 3.04 (7.34), 1.66 (4.90) 1.95 (4.87), 2.17 (4.43)
2B 2.96 (9.06), 1.42 (4.66) 2.44 (6.88), 1.41 (5.63) 1.18 (3.58), 1.19 (5.21)
3A 17.4 (40.4), 2.17 (6.23) 6.48 (22.0), 2.22 (5.05) 3.99 (7.50), 2.48 (4.95)
3B 7.93 (16.0), 2.10 (5.53) 4.06 (8.16), 1.99 (5.84) 3.18 (6.83), 2.04 (5.61)
Table 3.3: Observer variation evaluated at the isocentre. Tumour cannot be
delineated indicates proportion of projections clincian was unable to successfully
delineate the tumour.
Scan Observer variation Tumour not su ciently visible
ref. mean (maximum) to be delineated
1A 1.88 (4.65), 0.984 (2.75) 67%
1B 1.27 (3.87), 1.15 (3.36) 66%
2A 0.760 (2.40), 1.21 (3.79) 62%
2B 0.698 (2.06), 1.56 (7.55) 57%
3A 1.45 (3.78), 1.22 (2.75) 72%
3B 1.36 (3.78), 0.96 (2.75) 72%
48
tion model is an accurate reflection of the actual motion, the approach is able to
improve the MCR and recover the motion model parameters. Although the inten-
tion is for this method to be used to allow for markerless tracked RT treatments,
this method could o↵er benefits in marker-based treatments. Markers are much
simpler to enhance in the projections, only requiring thresholding in the case of
gold markers. This means, assuming the tumour position is accurately reflected
by the marker position, artefacts present from using the tumour enhancement
approach are avoided. By comparing the known measurements of the marker
with those taken from the MCR, a measure could be derived as to how well the
actual motion of the marker can be modelled by both the motion model and fitted
parameters.
The simulated experiment allowed the method to be evaluated on data unaf-
fected by CBCT-specific artefacts. However, the simulation was based on actual
patient data and contained fully deformable motion within the tumour region.
Since the ground truth was known, 3D errors could be calculated. The tumour
position could be determined to within 1 mm on average, with maximum errors
brought under 5 mm. These errors are of a clinically useful accuracy (under 5
mm) for motion management in radiotherapy [30].
The method was tested on a number of patient datasets exhibiting tumours
in di↵erent areas within the lung, moving to varying degrees. The 3D position of
the tumour at the time of each projection was not available for a ground truth
comparison. Indeed this is a reason markers have proven popular for tracking
tumours [61, 50]. To give some assessment of the ability of the proposed method
to correctly model the tumour position and motion, the tumour position was
manually identified in the projections by a clinical expert. Projections of the
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MCR were manually positioned by the clinician to best overlap the tumour on the
original projections. Using projections of the MCR allows the tumour position
estimated by the model and manually located tumour position to be directly
compared, providing an indication of the relative misalignment in the projections.
The misalignment between the tumour positions on the projections was scaled
so as to give the corresponding misalignment at the isocentre. This gives a more
meaningful estimate of the error as the tumour is likely to be located near the
isocentre.
Figure 3.8 shows the improvement in edge contrast of the tumour region after
motion correction. Qualitatively, this suggests that the fitted motion is reflective
of the actual tumour motion. The clinical delineations can be used to quantita-
tively assess the motion estimates made by the model. In the SI and transverse
directions, all of the maximum errors were within a clinically useful threshold
of 5 mm, if the maximum observer variations of each scan were taken into ac-
count. This also includes one case where the patient took a sharp breath, possibly
corresponding to a cough.
From previous studies of respiratory motion during SABR, it was hypothesised
that gated treatments may only be necessary for cases where the tumour motion
is larger than 10-15 mm [25]. It was deemed that treatment at the time-weighted
mean tumour position was adequate for the majority of cases. The presented
technique could be used to determine the time-weighted tumour position, requir-
ing a shorter acquisition sequence than that needed for 4D-CBCT. The extent of
tumour motion could then be assessed and used to determine if treatment at the
mean position, or if gated or tracked treatment is most suitable. The observed
motion could also be used to calculate the maximum possible duty cycle [41] to
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reduce the error in tumour position to acceptable tolerances.
The clinician was asked to repeat the alignment to understand the observer
variation. In all of the patient cases, error-reductions (relative to manually iden-
tified tumour positions) support the assumption that the tumour positions could
be estimated by the model well, given the observer variation. However, it is ac-
knowledged that the presented delineations were only repeated once, and all were
completed by the same clinician, on markerless data. This was the best possible
analysis given constraints on available data and clinician delineation time. The
mean and maximum errors in manually locating the tumour of up to 2 and 8 mm,
respectively, can be explained by the di culty of identifying the tumour edges.
In the majority of projections, the clinician was unable to delineate the tumour.
Given the di culties with identifying the tumour in the projections, the reported
inaccuracies do not seem unreasonable.
For sequential scans of the same patient, tumour motion does remain reason-
ably consistent. This would be expected, given the patient breathing should not
change dramatically between subsequent scans in the majority of cases. The three
patients exhibited di↵erent types of tumour motion and locations, demonstrating
the ability of the surrogate-driven motion model to be used in a variety of clinical
situations. For the patient with an upper lobe tumour, the method predicted
small surrogate-dependent motion, which was verified on the planning 4DCT.
For patient 2, tracking in the transverse direction provided an interesting
insight into the e↵ect on tumour position of a shift applied after the first scan.
The shift was done to better align the tumour with the target volume prior to
treatment. For this patient, this shift had the e↵ect of better aligning the tumour
with the machine isocentre, in the LR and AP directions (see Figure 3.9). If just
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the manually located tumour positions are used, it would not be possible to draw
this conclusion.
The method presented uses an optical tracking system to provide a surrogate
trace. It should be noted that a surrogate obtained by other means could also
be used, for example extracted directly from the projections themselves [77, 29].
The optical tracking system was adopted as it provided a consistent 3D reference
surface from which to produce a surrogate. For surrogates obtained via projec-
tions, it is not trivial to determine the 3D position of a projected feature, hence
extracting a surrogate una↵ected by projection angle from them is di cult. The
optical tracking system also utilises multiple pods, each producing a surface which
is stitched together. This is beneficial as a stable surrogate signal can be obtained
even as the gantry rotates, obscuring the view of select pods.
The limited field of view of the CBCT led to incomplete reconstructions of
transverse slices of the patient. This, in turn, introduced artefacts when generat-
ing the enhanced tumour projections. Because the scan is centred on the tumour,
the missing anatomy is on the side of the patient furthest from the isocentre,
which included parts of the chest, ribs, and lung. Most of the artefacts were
introduced in lateral projections of the CBCT. To improve the quality of data
available, it is recommended that the patient be scanned so as to allow complete
transverse slices. This would include o↵setting the detector further to increase
the field of view of the reconstruction, and aligning the centre of the patient with
the isocentre (rather than the tumour). However, even with artefacts in the en-
hanced tumour projections, a stable estimate of the motion model parameters was
attained. To check convergence, extra iterations were run after the stopping cri-
teria had been reached and the motion model parameters remained stable. The
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authors attribute the convergence properties to the form of the motion model
(rigid translation-only) and global matching (using all projections to update the
parameters) technique. The form of the motion model is to be extended to more
complex deformations, such as non-rigid motion. This would allow the rest of the
patient, including the organs at risk, to be monitored during gated and tracked
treatments.
The limitations of using a rigid-translation only motion model are acknowl-
edged. Although this is suitable for modelling the tumour motion, it cannot model
the motion of other parts of the anatomy that move di↵erently to the tumour.
For example the ribs in Figures 3.6 and 3.8c appear more artefact a✏icted in the
MCRs as they have had the tumour’s motion imposed on them. In the follow-
ing chapter, this methodology is significantly extended to incorporate non-rigid
deformations. This not only allows for potentially non-rigid motion within the
tumour region, but allows the motion of the whole region imaged by the patient
to be modelled.
53
(a)
(b)
(c)
(d)
Figure 3.5: Slices though MCRs for phantom data with (a) no motion compensa-
tion (b) 1 iteration of the algorithm and (c) 3 iterations. (d) Edge profiles along
indicated lines.
Figure 3.6: Sagittal slices of reconstructions around tumour region before (left)
and after (middle) motion correction. For comparison, the ground truth used in
the simulation is shown (right).
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Figure 3.7: Example CBCT projection before and after alignment of projected
MCR region by clinician.
(a) (b) (c)
Figure 3.8: Coronal slices of tumour region reconstructions, using original projec-
tions with (bottom rows) and without (top rows) motion compensation, for select
scans. Patient 1 (a) had a left upper lobe tumour with little respiratory motion.
Patients 2 (b) and 3 (c) both had right lower lobe tumours.
Figure 3.9: Motion estimated (solid black) and manually identified (dotted red)
tumour positions in SI (left) and transverse (right) directions, for first (top) and
second (bottom) scans of patient 2. The patient was shifted for better tumour
alignment between the scans. Units are in mm, scaled from projection to a parallel
plane passing through machine isocentre.
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Chapter 4
Moving to a whole patient
motion model
Upon achieving promising results, it was natural to consider how to extend the
model beyond that of simply the tumour region. I completely developed the
presented approach to building a fully deformable motion model, which attempts
to balance the complexities required from a fully deformable motion model with
the limitations of CBCT in the clinical environment. This includes understanding
that one only has a finite time with which to optimise the parameters of the motion
model (on the day of treatment) and, again due to restrictions on scanning time,
often needs to work with a limited number of CBCT projections. The results of
this work has led to first author conference and workshop publications, detailed
in chapter 7. Future work has also been influenced by the developments made in
this chapter.
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4.1 Introduction
Although knowledge of tumour motion is the most important feature to under-
stand, other regions of the patient can o↵er critical insight during RT treatment.
One of the key regions which is also important to track during RT treatment are
the OAR. These regions have been identified during planning and their exposure
limits were a key aspect in determining the most e↵ective dose plan to prescribe
to the patient. Unlike the tumour region, motion of the OAR cannot be encap-
sulated with a rigid-translation only motion model. This is because regions such
as the lungs cannot be described as a solid, non-deforming mass.
In this chapter, the previously described translation-only model is modified
and extended to a fully deformable one. Previously only applicable to the tumour
region, this new approach can now be used to track the tumour region and OAR.
This approach can now retain many of the advantages o↵ered by the previous
approach, but now accommodate for the demands of a fully deformable motion
model of the whole patient. With a fully deformable motion model, rich detail on
patient respiratory motion can be derived, and for example with tracked treat-
ments, it can be ensured that beam modifications to track the tumour region do
not over-expose the OAR.
A surrogate-driven motion model is used to overcome the di culties associ-
ated with real-time imaging of the internal anatomy. Once the model has been
built, only a new surrogate measurement is needed to estimate the patient state.
The surrogate can be monitored easily throughout treatment, avoiding implant-
ing markers or taking additional scans. The motion model is posed in a way
which exploits the relative strengths of the datasets most often available during
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RT treatment: The planning 4DCT and positioning CBCT. The higher quality
planning 4DCT is used to construct what will be termed weighting arrays. The
weighting arrays are essentially deformation fields within the model, which de-
scribe how the anatomy of the patient could vary with the surrogate signals. The
motion model parameters (after being weighted by the weighting arrays) are then
fitted to the CBCT, which can account for the inter-fraction variation that occurs
between planning and the day of treatment. The motion model parameters are
global in nature (same over the whole volume). This means the number of model
parameters to fit on the day of treatment is low and they can be quickly found.
The motion model is also robust against many of the previously mentioned prob-
lems a↵ecting CBCT. In addition, delineations from planning can be imported
onto the model, providing tumour and OAR boundaries based on those used to
construct the plan.
4.2 Methods
4.2.1 Modifying the model to account for non-rigid mo-
tion
During the CBCT scan, it is assumed that the patient motion can be described by
a series of deformations, Fn, of a motion-free image of the patient, Vref (x) : x 2
⌦CBCT . ⌦CBCT is the region imaged during the CBCT scan and n = 0, 1, ..., (N 
1) is an index corresponding to the time of each of the N projections. The
deformed patient volume, Vn, is then:
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Vn (x) = Vref (x+ Fn (x)) . (4.1)
A variety of non-rigid motion models [47] have been proposed in the literature. For
this work, a non-rigid motion model is required which can account for hysteresis
and changes in depth and length of breathing cycle. A non-rigid motion model,
similar in form to that used to for the tumour region-only motion model, is chosen:
Fn (x) = snD1 (x)   µ1 + s˙nD2 (x)   µ2, (4.2)
where   is an element-wise multiplication (Hadamard product). µ1 and µ2 are
the motion model parameters (3D vectors). sn and s˙n are the scalar surrogate
signal associated with the nth projection, and its rate of change, respectively. D1
and D2 are weighting arrays for µ1 and µ2 respectively. The weighting arrays
are deformation fields, returning a 3D vector at a point x in the patient volume.
The use of weighting arrays allows for spatially-dependent variations within the
model, which are essential for a fully deformable motion model of the patient.
The weighting arrays are pre-built from the planning 4DCT and remain fixed
during fitting of the motion model parameters. It is the final fit of the motion
model parameters that gives the day-specific estimate of the motion. The motion
model parameters are independent of position within the patient volume, hence
are global in nature.
One could think of (4.2) as a set of global, motion model parameters which
are spatially weighted by the weighting arrays. The motion model parameters
describe how key features of the respiratory variation (e.g. hysteresis, depth of
breathing) of a whole patient correlate with the surrogate signals, as seen in the
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CBCT projections. The weighting arrays then use this information to generate a
fully deformable motion model, which is based on anatomical variation seen with
respiration in the planning 4DCT.
4.2.2 Global/local approach to describing respiratory de-
formation
As far as the author is aware, decomposing the non-rigid motion model into local
and global components as in (4.2), in each spatial dimension, is conceptually new.
Because of this it is worth discussing this model in more detail.
The weighting arrays control the relative motion between di↵erent patient
anatomy, ultimately realising the non-rigid motion of the patient with changes in
the surrogate signals. The weighting arrays achieve this by specifying the distance
each part of the anatomy moves relative to the other, in each spatial dimension.
Therefore, the weighting arrays can be thought of as providing a local description
of the motion as they are dependent on spatial position.
The quality of the planning 4DCT is relatively high, making this scan a good
candidate to build the local description of anatomical variation with the surrogate
signals empirically. There are two weighting arrays, one to describe the local
variation with each surrogate signal. The magnitude of motion has not been
completely detached in their current implementation, although using normalised
weighting arrays would also be possible. The magnitude information is present as
the weighting arrays are built from a series of registrations between phases of the
planning 4DCT, and still contain physically relevant deformation information.
However, to account as much as possible for some of the inter-fraction variations
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(specifically baseline shifts, anatomical changes and some expected changes in
respiratory motion because of these changes) a registration between the average
4DCT and CBCT is used to move the weighting arrays to CBCT space.
The motion model parameters are fitted to the CBCT, and allow changes of
the respiratory motion, beyond that described in the local-based weighting arrays,
to be made. The changes to the respiratory motion that these parameters impose
are global in nature, as each parameter has the same value throughout the patient
volume. They act to essentially rescale, in each individual direction, the weighting
arrays over the whole volume simultaneously. These global parameters may then
give an indication of some more general features of the respiration seen on the
day of treatment. This could include the magnitude of the hysteresis e↵ect, or
the depth of breathing, as the surrogate varies. Figure 4.1 shows an example case
of the e↵ects of varying the motion model parameters and weighting arrays.
Although providing up-to-date information describing the daily motion and
anatomy of the patient, CBCT data poses a variety of problems. One key issue is
only projection data being available. Unlike phases of the 4DCT, whole volumes
are not available, with instead a long series of reduced-dimension (2D) X-ray pro-
jections. For each projection, this e↵ectively removes the information available
in the source-to-detector (isocentre) direction. For each projection, it would be
very di cult to have a well-enough constrained, local approach to building the
motion model empirically. For this reason, it makes sense to fit parameters to
the CBCT projection data which are well-enough constrained. The global nature
of the motion model parameters suitably constrain the fitting. All the projec-
tions can therefore provide an insight into the respiratory motion seen in each
dimension, avoiding problems caused by having projections instead of complete
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volumes. This approach also adds robustness to the fit. Over the whole volume,
the sensitivity of the method to other issues a↵ecting CBCT reconstructions, such
as artefacts (e.g. cupping, streaking), scatter and incomplete field-of-view, is re-
duced. On the day of treatment, this approach also allows for a low number of
parameters to be fitted. This greatly reduces optimisation time as the algorithm
used only needs to search a much reduced parameter space. The resulting cost
function to optimise is convex - it is of a positive-definite quadratic form with a
global, unique minimum. This removes the possibility of getting stuck in local
minima.
Having a fast-to-optimise cost function which can be robustly fitted to CBCT
potentially o↵ers a promising way to meet clinical requirements. The clinical im-
plementation of a next generation, tracked RT treatment system will need to meet
a variety of demands, such as quick model fitting on the day of treatment, and if
possible, a stepped approach to increasing the ability of current treatments. Easy
integration to current clinical protocol will also increase the target audience, as it
is more favourable to upgrade existing systems and keep changes to existing pro-
tocols minimal. Another point to note is that ideally one would simply upgrade
the CBCT to a di↵erent modality, for example 4DCT. However, clinical limita-
tions (e.g. cost, space available) prevent such a solution. The CBCT modality is
well integrated into, and is a critical element of, current RT treatments. This will
continue to be the case for the foreseeable future due to its popularity, practicality
and relatively low cost.
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4.2.3 New form of the cost function
A similar approach to that used to determine the parameters of the tumour only
motion model can be taken with this newly modified motion model. Explained in
the next section, the weighting arrays have been built and moved into the space
of the CBCT scan to then fit the motion model parameters.
As with the tumour only motion model, for an estimate of the motion model
parameters, a method is needed to update them. Similar to the derivation of the
cost function used to update the parameters of the tumour-only motion model,
equations (3.3,3.4,3.5) remain valid. Note, however, that the motion model is
now applicable to the whole of the patient. Therefore Vref is now referring to the
whole patient volume imaged during the CBCT scan rather than just the tumour
region. Vn is then the animated patient volume, using the model described by
(4.1). This changes the equation used to update the parameters to:
 µ = argmin
 µ
"X
n
X
pixels
(Rn   Pn (rVn ·  Fn))2
#
, (4.3)
where  Fn now takes the following form:
 Fn (x) = snD1 (x)    µ1 + s˙nD2 (x)    µ2. (4.4)
Substituting (4.4) into (4.3) and algebraically expanding (see Appendix A for
a detailed derivation), the cost function now becomes:
µ1, µ2 = argmin
µ1,µ2
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, (4.5)
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where
 0 = 1,
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 1
 2
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 4
 5
 6
1CCCCCCA = µ2. (4.6)
and
C0 = pn   Pn(Vn),
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C2
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0BBBBBB@
Pn (rxVn  D2,x)
Pn (ryVn  D2,y)
Pn (rzVn  D2,z)
1CCCCCCA .
(4.7)
The x, y, z subscripts of the weighting matrices indicate the relevant component
of the vector field.
To determine the various parts of the cost function requires multiple volume
deformations. Section 4.2.5 explores determining the updates to the undeformed
MCR as an option to greatly reduce the frequency of these calculations. A faster
algorithm is useful to make this approach more clinically acceptable.
4.2.4 4DCT, CBCT and moving weighting arrays to CBCT
space
4DCT scans are routinely used during planning to outline the tumour region
(including respiratory motion seen between phases) and OAR. In this work, 4DCT
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is used to build the weighting arrays via a series of registrations. The phases of
the 4DCT are referred to as Ipq, where p is a percentage and q ”In” (inhale) or
”Ex” (exhale). For example I100In is the 100% inhale phase of the 4DCT. Note
that in this notation I0In is equivalent to I100Ex and I100In to I0Ex.
Since D1 describes the spatially-dependent weightings of the motion model de-
formation due to the surrogate signal s, it can be built from registrations between
two phases of the 4DCT where s˙ is assumed to have the same value. Vice-versa for
building D2, which describes the spatially-dependent weightings due to s˙. Here,
D0In1 is built from a registration between I0In and I100In. D
50Ex
2 is built from reg-
istrations between I50Ex and I50In. The superscripts indicate that the weighting
arrays are in di↵erent spaces to what is needed for the motion model.
The weighting arrays need to be moved into CBCT space ⌦CBCT prior to
fitting the model. This is achieved by first moving the weighting arrays into a
common average 4DCT space, ⌦ave, followed by finally moving into CBCT space.
Note that one could think of ⌦ave and ⌦CBCT as the coordinate systems of the
4DCT and CBCT scanners, respectively. Assuming we have a homeomorphism
 a!b : ⌦a ! ⌦b between the coordinate systems ⌦a and ⌦b, the transformation
(each weighting array can be regarded as a transformation) Ta : ⌦a ! ⌦a in the
coordinate system ⌦a has a topological conjugate Tb : ⌦b ! ⌦b if [16]:
Tb =  a!b ⇤ Ta ⇤  1a!b, (4.8)
where ⇤ is a function composition. First the homeomorphism  0In!ave, is deter-
mined. This is calculated by averaging the deformation fields from registrations
of 0In to all the other phases of the 4DCT. D0In1 , currently in the space of ⌦0In
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is moved into the space of ⌦ave via:
Dave1 =  0In!ave ⇤D0In1 ⇤  10In!ave. (4.9)
D50Ex2 , currently in the space of ⌦50Ex can also be moved:
Dave2 =  0In!ave ⇤ 50Ex!0In ⇤D50Ex2 ⇤  150Ex!0In ⇤  10In!ave. (4.10)
The final stage of moving Davei , i = 1, 2 into the space of ⌦CBCT is performed on
the day of treatment. The average 4DCT image, Iave, is registered to a standard
reconstruction from the CBCT (with an initial rigid registration) to determine
 ave!CBCT , with
DCBCTi =  ave!CBCT ⇤Davei ⇤  1ave!CBCT . (4.11)
Figure 4.2 provides a diagrammatical representation of the various registration
steps. For the final registration step, the standard CBCT reconstruction is as-
sumed to be an approximation to the average image [35].
Registrations are critical to building the weighting arrays and moving them
to the space of the CBCT scanner. Therefore, description of the non-rigid local
motion hinge on robust registrations. Intra-modality are required between di↵er-
ent phases of the 4DCT. An inter-modality registration is also required, namely
between the average 4DCT scan and the CBCT reconstruction.
An open-source software package [48], was used for the registrations and to
calculate inverses of the deformation fields. The registrations are based on B-
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splines [58] with a control point spacing of 5 mm. Bending energy was used as a
constraint and normalised mutual information as the similarity measure. All the
resulting deformation fields had a positive Jacobian determinant throughout and
were assumed to represent a homeomorphism. To avoid errors being introduced by
artefacts and inaccurate registration results near the edges of the reconstruction,
a mask was applied to points in the weighting arrays within 10 voxels from the
edges of the reconstructed volume.
The approach could also be used with a variety of measures other than nor-
malised mutual information. For inter-modality registration, this measure may
be suitable, but for intra-modality registrations, an intensity-based measure may
o↵er a useful alternative. Another interesting alternative would be a registration
based on biomechanical constraints (e.g. finite element driven registrations).
4.2.5 MCR-based update to the parameters, form of cost
function
The full cost function (4.5,4.6,4.7) presented in chapter 4.2.3 requires deforma-
tions be taken for the time of every projection. These constant deformations
increase the computational workload. In order to greatly speed up the time
taken to solve the cost function, using a comparison with projections of the MCR
is proposed. Taking this approach means the whole model parameters will be
calculated at every iteration, as opposed to updates to the previous estimate of
the parameters.
By taking projections through the unanimated MCR, the cost function sim-
plifies to the following:
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µ1, µ2 = argmin
µ1,µ2
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#
, (4.12)
where Pn is the forward projection operator (nth projection), given the CBCT
geometry, and pn the actual CBCT projections. Algebraic expansion of (4.12)
allows the parameters to be factored out of the projection operator and summa-
tions. The cost function remains of a positive definite quadratic form and all the
sums over projections can be calculated prior to the optimisation step.
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(4.15)
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The x, y, z subscripts of the weighting matrices indicate the relevant component
of the vector field. The same software package used to calculate the MCR was
modified for the forward projections.
With this form, it is possible to determine the various aspects of the cost
function quickly. For example, projections of the undeformed MCR are taken,
completely removing the need to deform the patient volume at the time of each
projection. In the previous version of the cost function, projections of the gradient
of the deformed volumes, pre-multiplied by particular components of the deformed
weighting arrays (composed with the deformation), were needed. These now
become projections of the gradient of the MCR pre-multiplied by undeformed
weighting arrays. As it is essentially one, unchanging, 3D array which is being
projected, approaches tailored to quickly simulating a CBCT of one volume can
be modified for calculating various parts of this cost function. For this work, a
GPU-accelerated forward projector originally tailored to simulating CBCTs of a
patient volume was modified to determine the projections required for this cost
function.
WIth the GPU accelerated version, one CBCT acquisition consisting of around
350 projections can be simulated in under 15 seconds. If the patient volume needs
to be deformed prior to each projection, this time is increased to 3-4 minutes.
4.2.6 Iterative approach
As with the tumour only approach, an iterative method is taken to simultane-
ously determine the MCR and motion model parameters. The MCR is set as the
approximation to Vref , which should become more accurate as the parameters
produce an MCR which is more representative of Vref . An open-source, FDK-
69
based software package (www.openrtk.org) was modified to calculate the MCR.
MCRs are performed by back-projecting each projection through a deformed vol-
ume. The deformation to use should be the inverse of the forward transformation
from the motion model (i.e. F 1n from (4.2)).
An initial MCR is calculated assuming there is no motion (i.e. a standard
reconstruction is performed). This is then set as Vref and new estimates for µ1
and µ2 are calculated. The new estimates of the motion model parameters are
then used to recalculate the MCR, giving an improved estimate of Vref . The
process is then iterated until the convergence criteria are met. The algorithm
is terminated if the absolute change over all the parameter components are less
than 5% of their previous values, or had an absolute change of less than 0.005.
With reasonable assumptions (motion model parameters are all of the order of
0.5, maximum respiratory motion of around 20 mm), the termination conditions
correspond to changes less than 0.5 mm. The absolute threshold is used to avoid
changes in smaller parameter values (which will have a larger percentage change)
unnecessarily postponing convergence.
4.2.7 Masking the weighting arrays
In this approach, to avoid artefacts, or inaccurate registration results, near the
edges of the reconstructed volume overly e↵ecting results, a masking step was
used. Rather than mask the volume itself, the weighting arrays were instead
masked. This is essentially a switch to control which regions in the reconstruc-
tions are motion corrected, and which are not. (i.e. by masking the weighting
arrays, the anatomy in the masked positions will not be motion corrected when
calculating the MCR.) However, when the projections are taken, the anatomy will
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still be present, albeit with motion blurring. When determining the parameter
updates, di↵erences between estimated and actual projections are taken. With
the anatomy still being present in the estimated projections, the subtracted pro-
jections will have a closer match than if it was not present. Therefore with this
approach, without the benefit of motion correction, it is still possible to remove
this masked anatomy from the projections, which should improve the appearance
of di↵erences in non-masked regions (which is the region of the patient that is of
interest for fitting the motion model parameters).
Although in the ideal situation one would want motion correction in this
region, this approach stikes a balance between how much the artefacts near the
edges of the reconstruction will a↵ect the fit of the motion parameters, versus the
improvement from suitable motion correction in this region. Figure 4.3 shows the
e↵ects of motion correction with masked weighting arrays. Reconstructions with
and without motion correction are shown for an example sagittal slice through
the reconstruction, with the used masked delineated in red.
There are two interesting insights from using this masking approach: (i) If
the mask region was reduced to just the tumour region, and all the elements of
the weighting arrays set to one (rigid motion only), this approach simplifies to
the tumour-only case. This approach could therefore be considered as a more
theoretically complete version of the rigid approach, which can account for fully
deformable motion. (ii) With the current implementation, the motion model pa-
rameters describe some of the global properties of the patient respiratory motion.
One approach to make the parameters specific to a particular region, say OAR,
would be to set the mask to delineate that OAR. Therefore the motion model
parameters may be able to describe how that particular OAR deforms with the
71
surrogate signal, which may be more physically realistic.
4.3 Results
4.3.1 Simulated results
For this work, simulated data was used to assess the error reduction possible
after model fitting, as the true motion was known. CBCT acquisitions were
simulated using motion models built from actual patient 4DCT datasets. I0In
was transformed to the space of ⌦ave. The weighting arrays were in the space
of ⌦ave. The motion model parameters were then manually set to 0.5, inducing
respiratory motion approximately equal to that seen in the 4DCT. The I0In 4DCT
volume (moved into average 4DCT space) is used as the reference volume, and
is deformed by the motion model to simulate the motion seen during a CBCT
acquisition. A CBCT was then simulated from this, with the simulated motion
being driven by a real patient surrogate trace.
Simulated data of four patients were produced. There were variations over
the patients, including size, breathing pattern and tumour/OAR positions.
Three iterations of the algorithm were required to fit the models. Visible re-
ductions in blurring were seen in the reconstructions after motion compensation.
Figure 4.4 shows reconstructions using the fitted motions. Table 4.1 shows the
mean and maximum L2 norm errors before and after fitting the model for the
simulated cases. The errors are relative to the mean positions of the anatomy.
Tumour, lower lung and sternum regions were manually identified in the recon-
structions, for more localised analysis. The lower lung region is the lower part
of the ipsilateral lung. Over all simulated cases, the tumour motion was found
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Table 4.1: Mean (maximum) L2 norm errors for simulated datasets, in mm,
for various regions in the patient. Results are given with (MC) and without
(-) motion correction. For no motion correction, the anatomy is assumed to
remain at its average position. The various regions were manually identified in
the reconstructions. Lower lung refers to the lower part of the ipsilateral lung.
Patient Tumour Lower lung Sternum Whole volume
1 - 2.10 (6.21) 2.94 (18.2) 0.645 (2.28) 1.39 (29.9)
1 MC 0.401 (1.37) 1.32 (7.29) 0.216 (0.730) 0.479 (12.8)
2 - 4.15 (12.9) 3.99 (16.7) 2.51 (11.6) 1.41 (24.0)
2 MC 1.09 (3.50) 1.02 (4.61) 0.711 (3.22) 0.371 (6.58)
3 - 4.48 (14.8) 3.79 (11.9) 0.369 (1.95) 0.570 (21.8)
3 MC 1.37 (4.86) 0.866 (3.96) 0.101 (0.646) 0.178 (7.11)
4 - 0.444 (5.02) 1.84 (12.9) 0.404 (2.56) 0.534 (22.5)
4 MC 0.147 (1.78) 0.667 (4.76) 0.108 (0.678) 0.172 (8.38)
with a mean (max) L2 error over the entire CBCT of 0.752 (4.86) mm. Without
motion correction the L2 errors were 2.79 (14.8) mm. For the lower lung regions,
motion correction reduced the L2 errors from 3.14 (18.2) mm to 0.968 (7.29) mm.
For the sternum, L2 errors were reduced from 0.982 (11.6) mm to 0.284 (3.22)
mm.
4.3.2 Clinical results
4DCT planning scans and CBCT scans were collected from four patients under-
going SABR treatment at Guy’s and St. Thomas’ NHS Foundation Trust. An
Elekta Synergy (Elekta Limited, Crawley, London, UK) treatment machine, with
a CBCT scanner orthogonally mounted to the treatment beam, was used for the
SABR treatment. During the CBCT scans, synchronised 3D skin surface data
was acquired from Align RT, a stereo camera system (Vision RT, London, UK).
These surfaces were then converted to the raw 1D surrogate signal by taking the
average height between the couch and skin surfaces, within a manually defined
bounding box covering the chest and abdomen. The raw surrogate is smoothed
and normalised (mean subtracted; divided by standard deviation), yielding sn.
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s˙n is calculated using a finite di↵erence approach, and has been normalised with
its own mean and standard deviation.
Data from four patients were used in this study. These were the same patients
as those used to generate the simulated data. All CBCT scans took 1.5 minutes,
acquiring around 350 projections over a 360 degree rotation. Due to the dimen-
sions of the CBCT scanner, it was not possible to reconstruct complete transverse
slices for any of the patients. Therefore all the scans had patient anatomy lying
outside the reconstructed volume which was visible in the CBCT projections.
One CBCT scan (patient 3) was particularly a↵ected by scatter due to patient
size.
Unlike the simulated case, the true motion of the tumour and OAR are not
known. Indeed, attempting to understand the full motion is one of the fundamen-
tal drivers for this work in the first place. However, one indicator that the motion
during the scan has been predicted is achieving a sharper MCR, especially when
compared to assuming no motion. Regions of higher contrast, such as tumour or
OAR edges should have less motion blurring. Some examples of this are seen in
Figures 4.5. Accompanied with this there should be a higher signal to noise ratio.
One way to allude to this is to look at regions where one expects a constant value,
such as some parts of the tumour, rib, lungs and fatty tissues. Figure 4.6 shows
how the signal over the tumour region has a sharper transition at the tumour
boundaries, combined with a more constant value within the tumour up to the
boundary.
Over all the patients, the algorithm converged within five iterations. Visible
improvements in the MCRs were seen, such as increased edge contrast near the
diaphragm, chest wall and tumour regions. Figure 4.5 shows examples of these
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improvements, including the patient a↵ected by large amounts of scatter.
Figure 4.6 shows surface plots of a central plane through the tumour regions
of the two patients which exhibited the greatest motion. After motion correction,
both cases exhibit a larger signal within the tumour region, particularly near
the edges. Higher edge contrast is also seen after motion correction. Line profiles
through the diaphragms of each patient’s ipsilateral lung show sharper transitions
between the lower lung and diaphragm after motion correction.
4.3.3 Approximation to inverse deformation field of model
By updating the whole motion model parameter from comparisons with projec-
tions of the MCR (rather than animated volume), simulations of the projections
can be GPU accelerated. However, at this stage, calculation of the MCR is not
GPU accelerated, and is the most time-consuming part of each iteration of the
algorithm. Much of the time in determining the MCR is used in determing the
inverse transform of the motion model at the time of each projection.
One interesting approach to significantly reduce the time taken to calculate
the MCR can be made by simply approximating these inverses with the negative
of the forward transformation. This, strictly, introduces errors into the recon-
struction, especially for large deformations. This is due to the sampling point
in the deformation field to determine the actual inverse not being the same as
the point in the deformation field at which the inverse deformation is required.
The only time these would be coincident is for zero deformation. Figure 4.7 visu-
ally demonstrates how assuming a negative forward approximation to the inverse
introduces errors, compared to the actual inverse.
Although Figure 4.7 demonstrates how errors can be introduced into the cal-
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culation of the MCR with increasing size of deformation, for the actual datasets
used, the introduced errors stayed relatively small. Interestingly, for the simu-
lated data, this approximation was able to determine the fitted motion across all
cases with an L2 norm maximum error of under 0.836 mm, compared to using
the full inverse. The mean error, over all simulated cases with this approximation
was 0.0194 mm. For the actual data, using the approximated inverse found the
parameters within 1.46 mm, with a mean error of 0.00605 mm.
One possible explanation is that over the whole CBCT, the occurances of
extremal deformations are relatively small, compared to the number of smaller
deformations. Smaller deformations sample the deformation field close to the
actual position needed to determine the true inverse value, hence resulting in a
small error with the negative forward transformation approximation. The result-
ing MCR from deformations of each back-projections using these approximated
inverted deformation fields are therefore close to the MCR when using the actual
inverse deformation field. The approximated MCR will therefore result in fitted
motion model parameters which are close to those fitted with the actual MCR.
One clear benefit of using the negative forward deformation approximation is
a significantly reduced MCR calculation time. For a CBCT scan consisting of
around 350 projections, and reconstruction size 300x300x150 1mm3 voxels, the
MCR can be calculated in around 3 minutes. If the full inverse is to be fully
determined for each back-projected volume, this time is significantly increased.
Using an ITK-based iterative method to determine the inverse resulted in a cal-
culation time of over 30 minutes. This approach then, may o↵er a good way to
practically reduce the time to calculate an MCR without overly compromising on
results. It may also be a good way to quickly build a first guess at the model,
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prior to a more accurate (but longer to calculate) update.
4.4 Discussion and conclusions
Key to obtaining an accurate fit is building the weighting arrays and moving
them to the space of ⌦CBCT . For the final step, a registration between a standard
CBCT reconstruction and the average 4DCT is performed. This assumes that the
blurring seen in the CBCT is an approximation to the average of all the patient
states seen over the CBCT [35]. Since the weighting arrays are derived from
sharper images, the registration of two images with blurred edges may result
in misalignment of regions of rapid variation in the motion, for example the
lung/chest-wall boundary. This issue may be further exacerbated as the MCR
becomes more defined with iteration number. After the first iteration, a possible
alternative method to that presented could be to derive the final transformation
to CBCT space. This would be based on a further registration between a phase
of the 4DCT (e.g. I0In), moved to the space of ⌦ave, and the MCR. The authors
plan to investigate alternative ways to build the weighting arrays and move them
into the space of ⌦CBCT . Other areas for future research are the use of di↵erent
modalities to build the weighting arrays and the use of registration techniques
that can account for sliding between the lungs and chest wall (e.g. [14]).
Prior to fitting the model, a masking step was used to minimise the e↵ects of
artefacts and inaccurate registration results near the edges of the CBCT recon-
struction. Instead of masking the MCR itself, the weighting arrays were masked.
This produced full CBCT projections whilst masking the derivative-derived pro-
jections for the cost function. This approach is advantageous as during the pro-
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jection subtraction, regions outside of the mask will have been reconstructed with
no motion correction, hence will be included in the simulated CBCT and sub-
tracted from the original projections. This reduces the e↵ects of these regions
prior to the model fitting step. Interestingly, if the mask region was reduced to
just the tumour region, and all the elements of the weighting arrays set to one
(rigid motion only), this approach simplifies to that presented in [28]. This ap-
proach could therefore be considered as a more theoretically complete version of
the rigid approach, which can account for fully deformable motion.
A common approach for patient set-up is to centre the tumour region on
the isocentre of the treatment machine. Due to the limited size of the CBCT
detector, this almost always results in incomplete transverse slices of the patient.
The e↵ect of incomplete transverse slices is anatomy being visible in the CBCT
projections which are outside the field-of-view of the reconstructed CBCT volume.
Despite the CBCT having an o↵set detector for an increased field-of-view, all of
our patient datasets su↵ered from this problem. The presented approach appears
to be robust enough to cope with additional anatomy in the projections. This is
probably due to the use of the 4DCT data to build the weighting arrays, which
has a larger field-of-view than the CBCT reconstruction, and form of the cost
function. Better ways to account for this anatomy, for example to centre the
CBCT scanner on the patient centre (to obtain images more like that used for
the simulated data), or use di↵erent reconstruction techniques (e.g. iterative
reconstruction [3]) to more accurately account for partially sampled regions, are
being considered for future research.
A useful property of the proposed approach is its amenability to fitting a model
within a clinically useful timeframe. Due to the form of the motion model, only
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the motion model parameters need to be fitted on the day of treatment, which can
be done very e ciently (optimising the cost function takes seconds). The most
time consuming parts are simulating projections, performing reconstructions and
calculating the average 4DCT to CBCT registration. All of these are amenable
to speeding up via parallelisation. Work is currently underway to reduce the
time taken using GPU technology. With appropriate improvements, the authors
expect the model fitting to be completed in under 5 minutes, which is compatible
with the current clinical workflow. Depending on the number of iterations and
quality required of the MCR, the current implementation can take upwards of 15
minutes to fit the model.
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Figure 4.1: Example sagittal slice of patient volume undergoing deformations
via weighting array formulation of motion model described in equation (4.2).
Reference volume shown in top row, with di↵erence images (between the reference
volume) in subsequent 3 rows. In this example, D1 and D2 deformations have
been limited to the SI and AP directions, respectively.
80
Figure 4.2: Simplified diagram of registrations to build weighting matrices and
move them into the space of ⌦CBCT . Black arrows (dashed and solid) indicate
registrations needed to determine  0In!ave. Solid arrows indicate registrations
needed to build D0In1 (black) and D
50Ex
2 (red). The blue arrow indicates the
registration required for  ave!CBCT
Figure 4.3: Sagittal slice of example reconstruction to demonstrate e↵ects of
masking weighting arrays. Reconstruction without (left) and with (right) motion
correction, using masked weighting arrays. Mask used shown in red, with field
values outside the rectangles set to zero.
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Figure 4.4: Coronal slices of reconstructions before (top) and after (bottom)
motion compensation with fitted model, for simulated cases. Slice positions are
chosen to intersect with the tumour region. Red arrows and circles indicate areas
of improvements with motion correction.
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Figure 4.5: Sagittal and coronal slices of patients 1 (bottom left), 2 (top left), 3
(top right) and 4 (bottom right). For each patient, reconstructions without (top
row) and with fitted (bottom row) motion correction are given. Patients 2 and 3
exhibited the most motion. Slice position intersects with isocentre of the CBCT
scanner, which is approximately aligned with the tumour region. Red arrows and
circles indicate areas of improvement with motion correction.
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Figure 4.6: Surface plots of a central plane through the tumour region of patients
2 (top) and 3 (bottom), before (left) and after (middle) motion correction. Edge
profiles (right) are shown for a vertical profile passing through the diaphragm
in the ipsilateral lung. Profiles prior to motion correction are in dashed black,
and after motion correction in solid red. Note that patient 3 su↵ered from large
amounts of scatter, resulting in a noisy reconstruction.
Figure 4.7: Visualisation of error from approximating true inverse with the nega-
tive of the forward transformation. For a deformation field f , f(a) is the point to
sample to determine the true inverse at point b (i.e. f(b) 1 =  f(a)). The error
f(a)  f(b) is that resulting from approximating the inverse with the negative of
the deformation field sampled at b (i.e. f(b) 1 ⇡  f(b)).
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Chapter 5
Fully deformable motion model
from CBCT
This chapter is the result of an idea I had to try and describe the changes that
occurred between two projections, seperated by a small time step. The devel-
opments in this chapter are completely my own. The main contribution in this
chapter are the concepts behind how to obtain 3D directional information from
2D projections of the CBCT, and computational implementation of the method
on patient data. This work has led to first author conference publications detailed
in chapter 7, as well as stimulating much future work.
5.1 Introduction
In the previous chapter, a complete motion model of the whole patient is built
by splitting the fitted motion into local and global parts. The 4DCT and CBCT
are each used to determine the final fitted motion, utilising the various strengths
of each dataset.
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In this work, we assume that the higher quality, older 4DCT scan is not
available. This means the entire non-rigid motion model needs to be fitted to the
CBCT. This situation may be useful in situations where large variations are to
be expected between planning and the day of treatment. It could also be used to
modify the fitted motion using the constrained non-rigid approach in particular
regions where large variations may be present, making a fully non-rigid fit to the
CBCT data a more suitable approach.
Unlike the previously presented methods, the updates to the motion model
are determined in 3D patient space, as opposed to in projection space. A novel
method to determine voxel-wise updates to the motion model by extending an
optical-flow based method. A modified CBCT reconstruction is proposed, which
measures the di↵erences between the actual and current estimate of the motion,
and how these di↵erences correlate to the surrogate signals of the motion model.
From these reconstructions, the current estimate of the motion can be updated
via an analytical expression. It is envisaged that this approach be used to as-
sess respiratory motion immediately prior to treatment, particularly in situations
where large inter-fraction variations are expected. These could include weight
loss, tumour shrinkage or lung region collapse. Results on a simulated case are
presented.
5.2 Methods
5.2.1 Motion model updates
Similar in approach to the constrained non-rigid motion model, it is assumed that
the patient motion can be described by a series of deformations, Fn, of a motion-
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free image of the patient, Vref (x) : x 2 ⌦CBCT . ⌦CBCT is the region imaged
during the CBCT scan and n = 0, 1, ..., (N   1) is an index corresponding to the
time of each of the N projections. The deformed patient volume, Vn, is then:
Vn(x) = Vref (x+ Fn(x)) . (5.1)
Fn is parameterised by a motion model which can take into account hysteresis
and variations in length and depth of breathing cycle:
Fn (x) = sn 1 (x) + s˙n 2 (x) , (5.2)
where sn and s˙n are the scalar surrogate signal associated with the nth projection,
and its rate of change, respectively.  1 and  2 are the motion model deformation
fields, which determine a spatially-dependent, linear relationship to sn and s˙n
respectively. Comparing with the constrained non-rigid motion model (4.2),  1
and  2 contain both local and global components of the motion. In this particular
case, the motion is to be completely found from the CBCT, making separation
of the components into global and local constituents unfavourable.
As with previous work [28], the authors opt to use the Align RT camera system
(Vision RT, London, UK) to produce the surrogate signal. The optical stereo-
camera system is used to produce high-resolution surface images of the patient’s
chest. A region of the patient chest (enclosing parts of the thorax and abdomen)
is chosen and the average height above the treatment couch within this box is used
as the raw surrogate signal. After calculating the derivative trace, both traces
are then normalised (mean subtracted; divided by standard deviation) giving the
final surrogate traces.
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5.2.2 Determining  1 and  2
If the motion free image of the patient were known, a Taylor expansion can be
used to approximate the first order correction,  F estn , to an estimated deformation
field, F estn :
(5.3)Vn(x) = Vref
 
x+ F estn (x) +  F
est
n (x)
 
⇡ V estn (x) +rV estn (x) ·  F estn (x).
In terms of updates to the motion model, the first order correction can be written:
 F estn = sn  1 + s˙n  2. (5.4)
Note that   1 and   2 are defined in the space of Vn. Substituting the motion
model updates (5.4) into (5.3), and rearranging:
(5.5)Vn   V estn ⇡ rV estn · (sn  1 + s˙n  2) .
A demons optical flow approach [67] can then be used to specify the form of
the motion model deformation fields  1 and  2:
sn  1 + s˙n  2 ⇡ rV
est
n
(rV estn )2
 
Vn   V estn
 
. (5.6)
Updates to each motion model deformation field are desired. This is achievable
by exploiting the covariance between the surrogate signals. First multiply both
sides of (5.6) by sn, sum over all n and divide by the number of patient states
seen over the CBCT scan (i.e. number of projections), N :
var(s)  1 + covar(s, s˙)  2 ⇡ 1
N
X
n
rV estn
(rV estn )2
sn(Vn   V estn ), (5.7)
where var(s) = 1N
P
n s
2(n), covar(s, s˙) = 1N
P
n s(n)s˙(n). Because the surrogate
signals have been normalised (mean subtracted; standard deviation divided), var
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and covar are Pearson correlation coe cients and can be simplified: var(s) = 1
and covar(s, s˙) ⌧ 1. The latter simplification comes from the approximation of
independence between the surrogate signals. The proposed approach could still
be used without this approximation, but an additional set of linear equations
would need to be solved. Note that satisfying independence could be used as a
condition for choosing a suitable set of surrogate signals. The simplified form of
(5.7) is:
  1 ⇡ 1
N
X
n
rV estn
(rV estn )2
sn
 
Vn   V estn
 
. (5.8)
By approximating the sum of all patient states seen over the CBCT by a FDK
CBCT reconstruction [19, 35], it is possible to approximate the right side of (5.8)
using an FDK reconstruction [57], giving:
  1 ⇡ 1
N
X
n
rV estn
(rV estn )2
snP
†
n
 
pn   Pn(V estn )
 
, (5.9)
where pn are the CBCT projections, Pn the projection operator and P † the FDK
back-projection operator. A similar equation results for   2 by multiplying (5.6)
by s˙n instead of sn:
  2 ⇡ 1
N
X
n
rV estn
(rV estn )2
s˙nP
†
n
 
pn   Pn(V estn )
 
. (5.10)
The approximation is essentially using the reconstruction of the di↵erences (in
projection space) as an approximation to the average di↵erences in 3D space.
The multiplication by the the surrogate is additionally determining which of the
di↵erences are correlated with changes in the surrogate signal. As an analogy, if
the projections were simply of the animated patient volume, this approximation
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would correspond to the assumption that the reconstruction is an estimate of the
average of all the states seen over the CBCT in 3D space.
Here the average patient state seen over the entire CBCT is approximated as
the standard FDK CBCT reconstruction, as well as the average estimated patient
state over the CBCT represented using a standard FDK CBCT reconstruction
of the animated CBCT projections. Since the radon transform is additive, these
approximations can be written, with the reconstruction of the subtracted pro-
jections (original minus estimated projections) being an estimate of the average
di↵erences between the actual and animated patient volumes, throughout the
CBCT.
5.2.3 Iterative approach
In practice, Vref is not accurately known, as this would require knowledge of the
exact respiratory motion from which to perform an MCR. In this work, an itera-
tive approach is taken, with improving estimates of the motion model deformation
fields and MCR with each iteration. Starting with a zero motion assumption (i.e.
 1 =  2 = 0), perform an MCR, V 0, and set it to Vref . The updates to the
motion model deformation fields   01 and   
0
1 are then calculated, and the fields
updated via:
 1i =  
0
i +   
0
i for i = 1, 2. (5.11)
The updated motion model deformation fields can then be used to determine the
updated MCR and the procedure repeated.
For this work, a fixed number of iterations was set. Ten iterations were run
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with the updated motion model deformation fields having Gaussian smoothing ap-
plied prior to composition. To reduce calculation time, V
est
n
(V estn )
2 was approximated
by a Gaussian blurred Vref , as
Vref
(Vref)
2 , allowing it to be moved outside the sum-
mation in (5.9,5.10) and applied in one step. The Gaussian blurring applied was
the same as that used to smooth the motion model deformation fields. To ensure
that the optical flow equation is not unstable at small values of rV estn , updates
to   1 and   2 were set to zero if (rVref )2 +
 
1
N
P
n s˙nP
†
n (pn   Pn(V estn ))
 2
< ",
where " was empically set to 5⇥ 10 5.
5.3 Results
5.3.1 Simulated results
The method was tested on a simulated case, built from the 4DCT of an actual
patient undergoing radiotherapy treatment. End exhale was registered to each
of the seven other phases of the 4DCT and used to determine a transformation
to average 4DCT space. Registrations were used to determine transformations
from end-inhale to end-exhale, and from mid-exhale to mid-inhale. These trans-
formations were used to determine  1 and  2. The end-exhale phase, moved to
average 4DCT space was then animated using  1,  2 and an actual patient sur-
rogate trace. The accompanying CBCT geometry information for the respiratory
trace was used to simulate a CBCT of the animated volume.
After motion correction, improvements in the quality of the MCR were seen.
Figure 5.1 shows coronal slices through the tumour region of the patient volume
before and after motion correction. The regions of greatest improvement were in
the diaphragm and tumour region. The ribs were also seen to have fewer streak
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Figure 5.1: Coronal (top) and sagittal (bottom) slices, intersecting the tumour
region, of MCRs before (left) and after (middle) fitting the motion model.
artefacts, especially in the SI direction.
CBCT projections of the animated MCR with the fitted motion were seen to
be more similar to the actual projections, than projections of the unanimated no
motion reconstruction. Over all the projections, the SSD error was reduced by
12%, from 1.6⇥ 109 to 1.4⇥ 109. This also corresponds with an improvement in
similarity between actual and fitted motion model deformation fields, compared
to assumming no motion. Over the whole patient, mean L2-norm errors decreased
from 1.4 to 0.46 mm. In the tumour region, the mean L2-norm error was decreased
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from 4.2 to 2.6 mm. A movie of the original (left) and simulated (right) CBCT
projections with the fitted motion have been included as supplementary material.
5.4 Conclusions and future work
An iterative approach to build a surrogate-driven motion model entirely from
CBCT is presented. This approach could be used to reduce respiratory artefacts
in CBCT reconstructions, and as an intensity-driven way to estimate patient
motion when only the CBCT scan is available.
In its current form, the initial estimate of the motion is zero (no motion).
As the whole motion model is built entirely from the CBCT, this was used as
no prior knowledge of the motion is assumed to be known. One way to improve
upon this estimate would be to use the prior information from the 4DCT plan-
ning scan, or perhaps from previous treatments’ CBCT scans, as the starting
estimate. Although inter-fraction variations may have occurred, this initial esti-
mate is more likely to be closer to the actual motion than assuming no motion.
For cases where a prior CBCT-fitted model exists, a registration between the two
CBCT reconstructions (without motion correction) should be suitable to move
the motion model to the latest day of treatment. For the 4DCT planning scan
approach, an approach similar to the previous chapter (Chapter 4) could be used
to move the motion model to CBCT space.
In higher constrast areas, there is a visible reduction in motion artefacts in
the MCR using the fitted motion. This is because the gradient-based updates
rely on changes in intensity within the images to provide an accurate update.
However, in regions where this contrast is not available, the updates may not
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be as accurate. Smoothing is one way to regularise the updates over the entire
patient volume, as well as provide an estimate of the how to update the model
in regions of low contrast. One areas of future research, which may improve the
accuracy of update in these regions is to combine the presented approach with the
constrained non-rigid approach in Chapter 4. For example, the constrained non-
rigid approach could be used to provide the first estimate of the patient motion,
with the presented approach then being used to update this estimate further.
As well as improving upon the accuracy in low contrast regions, the proposed
approach may also be able to improve upon the constrained non-rigid approach.
This improved accuracy may be in regions of high contrast which show large
inter-fraction variation from planning.
It is acknowledged that hard termination conditions were set with the simu-
lated case. For di↵erent patients, each exhibiting di↵erent motion, a hard con-
straint such as this may result in di↵erent errors on their fitted motion models.
For future work, it is intended to add termination conditions, for example on the
magnitude of the average update, to determine whether enough iterations have
occurred to suitably describe the motion seen throughout the CBCT scan.
With termination conditions set, it is likely that many iterations will be re-
quired to suitably describe the motion. To be of clinical use, the number of
iterations should be as low as possible. One way to reduce the number of itera-
tions would be to include a more physical basis for updating the motion model, to
satisfy the termination conditions in fewer iterations. The authors are planning to
investigate a more physically justified basis for the direction-vector updates (i.e.
alternatives to rVref(rVref )2 ) to achieve these aims. Using a more physically justified
update may also help reduce the e↵ect of the relatively poor quality CBCT scan
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on the updates.
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Chapter 6
Future work
6.1 Further trials with more patients, better in-
tegrated equipment
Three general approaches to modelling motion of a patient undergoing tracked
RT treatment has been presented. Each method has its own advantages and
disadvantages and therefore potential uses. Two of the methods presented results
on actual patient datasets and one on a simulated dataset. In order to better
understand the behaviour of the presented methods with actual data, all the
approaches should be applied to a larger number of patient cases.
Having results on a larger set of patient data will allow the authors to un-
derstand in more detail the reliability, accuracy and general applicability of each
method. After these key issues are understood in more detail, it would be possi-
ble to make a more concrete conclusion as to which method provides the largest
overall benefits during tracked RT treatments. The selected method, then, can
be the first approach which is pursued further with regard to an actual clinical
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implementation.
Key to a clinical implementation is having a highly optimised, e cient algo-
rithm. Where there is no motion correction, GPU acceleration is currently used
to reduce the processing time as much as possible. If possible GPU-accelerating
both the simulated projections of the animated volume, and an MCR should be
given serious consideration. If both of these processes can be reduced to under
20 seconds per calculation, constrained non-rigid method presented in Chapter 4
can be made clinically useful. Note that for the tumour-only method presented in
Chapter 3, if the reconstructed region is centred around the tumour and kept small
(e.g. 100 sided-cube of 1 mm3 voxels) the model can be fitted within a clinically
useful timeframe. For the fully deformable method presented in Chapter 5, many
iterations will probably be required. Therefore simply using a GPU-accelerated
projector of the animated volume and MCR may not be enough given the number
of iterations. In addition to this, it would be worth providing a better starting
estimate of the motion, described in more detail later in this chapter.
Some of the latest SABR treatment equipment has features which would make
the integration of this approach easier than utilising existing equipment. For ex-
ample the Elekta TrueBeam features access to the live-streamed projections of
the CBCT, which would make it much simpler to fit the model during or immedi-
ately after the CBCT scan. Currently, the CBCT projections must be transfered
to hard disk post-fraction and processed o↵-site. In order to maximise expo-
sure to this next generation equipment, key partnerships should be considered
with groups who will have access to this equipment. Due to the likely timescale
for tracked RT treatments to become more accepted, it is likely that this next
generation equipment will be standard by that time. The correct choice now of
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equipment to develop the clinical implementations of the methods, will result in a
smoother transition to the clinic when tracked treatments become more accepted.
6.2 Multiple region motion models within con-
strained non-rigid approach
For the constrained non-rigid approach, the motion model parameters are global
in nature, in each respective dimension. This means there is one assumed rela-
tionship with the surrogate signal throughout the patient volume. An extension
of this approach results from questioning whether these global parameters should
indeed be the same throughout the patient. For example, the lungs and chest wall
slide past one another and simply accounting for the majority of the inter-fraction
variation by the registration between planning 4DCT and CBCT reconstruction
(i.e. by modifying the weighting arrays, or local component of the motion model)
may not be enough. In this example, it may be better to split the patient into
regions (e.g. lung and non-lung), each with their own regional parameters, as
opposed to global parameters over the whole patient. This means each region
will now have a distinct relationship to the surrogate signal, rather than simply
fitting the global parameters over the whole patient.
A brief description of the necessary modifications to the cost function follows.
For a patient divided into I non-overlapping regions (all of patient belongs to a
region), each with an independent surrogate dependence:
F (x, s(n), ) =
IX
i=1
F (x, s(n), i) . (6.1)
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Note that the subscripts of   do not correspond to iteration number but re-
gion. F (x, s(n), i) = s(n)D1(x)    1,i + s˙(n)D2(x)    2,i.  1,i and  2,i are the
motion model parameters for the ith region (surrogate-dependent and surrogate-
derivative-dependent, respectively). The deformation field updates are:
 F =
IX
i=1
F (x, s(n),   i) , (6.2)
where F (x, s(n),   i) = s(n)D1(x)   1,i+ s˙(n)D2(x)   2,i. Note here we assume
each region can deform non-rigidly. It is possible to impose rigid translation-only
motion (useful for certain situations, such as modelling tumour region) by filling
the weighting matrices with ones. For convenience, let F [ i] = F (x, s(n), i) and
F [  i] = F (x, s(n),   i).
The estimated patient volume, at the time of the nth projection, is now:
V [n] = Vref
 
x+
IX
i=1
F [ i]
!
=
IX
i=1
 
V iref (x+ F [ i])
 
, (6.3)
where V iref is Vref masked by region i. For notional convenience, let V
i
ref (x+ F [ i]) =
Vi[n], where again the subscript denotes a region and not iteration number. The
cost function also requires modification:
   = argmin
  
0@X
n
X
pixels
 
r(n)  Pn
 
rV [n] ·
IX
i=1
F [  i]
!!21A . (6.4)
The sum over regions can be brought outside the projection operator, giving the
following expanded form of the cost function:
   = argmin
  
"
IX
i=1
6X
✓, =0
 ✓,i  ,i
X
tn
X
pixels
C✓,iC ,i  ,✓
#
, (6.5)
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 0,i = 1,
0BBBBBB@
 1,i
 2,i
 3,i
1CCCCCCA =   1,i,
0BBBBBB@
 4,i
 5,i
 6,i
1CCCCCCA =   2,i. (6.6)
and
C0,i = r(n),
0BBBBBB@
C1,i
C2,i
C3,i
1CCCCCCA =  s(n)
0BBBBBB@
Pn (rxVi[n]  D1,x)
Pn (ryVi[n]  D1,y)
Pn (rzVi[n]  D1,z)
1CCCCCCA ,
0BBBBBB@
C4,i
C5,i
C6,i
1CCCCCCA =  s˙(n)
0BBBBBB@
Pn (rxVi[n]  D2,x)
Pn (ryVi[n]  D2,y)
Pn (rzVi[n]  D2,z)
1CCCCCCA .
 ✓,  =
8>><>>:
I 1 if ✓ =  = 0
1 otherwise
.
(6.7)
Note that projections of the ith animated patient region, Vi[n], is needed to bring
the spatially independent parameters for that region out of the projection oper-
ator.
For this particular form of the cost function, a critical issue is how to deal with
the transition between regions. If a simple implementation is made, the regions
will e↵ectively result in patient anatomy overlapping if one is not careful with
region selection. If the regions correspond to edges of the anatomy, this may not
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be the case, as long as the overall deformations remain small enough. However,
instead of relying on small deformations, it would be better to impose some form
of constraint on the final motion model estimate given the fitted motion. The
most simple method to implement would be to apply a smoothing after each fitting
of the regional motion model parameters. This would ensure that the changes
in estimated motion at the boundaries were not too extreme. However, for the
lung/chest-wall boundary, an extreme change may be precisely what is needed.
Alternative methods could be to then apply some form of bio-mechanical-based
smoothing to the fitted motion. For example, one would expect sliding between
the chest wall and lung, so no smoothing would be made at this boundary. For
boundaries between regions with expected similar deformations, smoothing would
take place to prevent large discrete changes in the estimated motion.
Another interesting approach would be to alter the directions of the region
motion model parameters (i.e. they will no longer be in SI, AP and LR directions).
[14] describe a b-spline-based approach to describing a patient divided into lung
and non-lung regions, which can account for sliding between the lungs and chest
wall whilst providing a smooth transformation between the regions. Based on
this approach, it is now assumed that the voxel-wise description of the motion
model will be generated from a b-spline-based description of the motion model.
Registrations between the phases of the 4DCT used to generate the weighting
arrays within each region will be done using the approach described in [14]. From
these registrations, once moved to the CBCT space, there will now be a regional
b-spline-based description for the weighting arrays along with an array which
details each region. The voxel-wise description of the global and local components
of the constrained motion model can now be deduced from these constituents.
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Critical to ensuring smooth transitions between regions are the arrays detailing
the various regions. This is because the direction vectors parallel and orthogonal
to the region boundaries are needed to ensure the smooth transitions. In order to
use this method and still retain the local and global form of the motion model, the
global motion model parameters are now directed parallel and orthogonal to the
region boundaries (rather than in SI, AP and LR directions). By modifying the
cost function to account for this form of the motion model (the key change would
be modifying the direction to sample to calculate the gradient-based terms of the
cost function), this approach could be a promising way to have multiple regions of
anatomical relevance modelled, with smooth transitions between regions modelled
whilst still accounting for sliding at the region boundaries. The cost function also
retains many of the attractive properties of the constrained non-rigid motion
model approach, for example a cost function of positive definite quadratic form,
and fitting the motion based on the respective strengths of the available datasets
(weighting arrays based on high quality 4DCT; global properties based on day-
specific but poor quality CBCT).
6.3 More physically-based updates to motion model
in fully non-rigid approach
For the fully deformable approach described in Chapter 5, the updates to the
motion model are oriented in the direction of greatest change in the gradient.
For some parts of the patient anatomy, for example the ribs, this assumption is
incorrect. Heavy smoothing can be used to reduce the impact of these incorrect
orientations at each iteration, and a large number of iterations used to eventually
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determine the correct motion. However, it may be possible to better constrain the
updates to the motion model by using an anatomically-based orientation instead.
Looking at the update equations (5.9,5.10), one can decompose them into two
parts, a magnitude and direction parts. For 1 these are
1
N
P
n
1
(rV estn )2 snP
†
n (pn   Pn(V estn ))
and rV estn , respectively. For  2 the direction component is the same and magni-
tude is 1N
P
n
1
(rV estn )2 s˙nP
†
n (pn   Pn(V estn )).
It is possible to relate  1 and  2 in equation (5.2) to the form of the con-
strained non-rigid motion model (4.2):
 i (x) = Di (x)   µi for i = 1, 2. (6.8)
It is possible to consider fitted constrained non-rigid motion model Di   µi as
deformation fields which describe how the anatomy is expected to move. Because
of the way they were constructed, the weighting arrays need to be normalised to
extract just the orientation information of these deformations.
I propose the following as an initial modification to the update equations, to
perform an update based on an anatomical-derived basis, as opposed to com-
pletely gradient based:
  1 ⇡ 1
N
X
n
D1   µ1
|D1   µ1|
     rV estn(rV estn )2
     snP †n  pn   Pn(V estn )  , (6.9)
  2 ⇡ 1
N
X
n
D2   µ2
|D2   µ2|
     rV estn(rV estn )2
     s˙nP †n  pn   Pn(V estn )  , (6.10)
The reasoning for the modification to the gradient-based term,
    rV estn(rV estn )2    , is
as follows. Although here we attempt to remove reliance on the gradient-based
term, it cannot be completely omitted as it also provides a key part of the update.
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The gradient provides information on how the underlying physical deformations
relate to intensity changes within the image. Since the new orientations, Di µi|Di µi|
are normalised the magnitude of the gradient-based term allows the orientation
information to be scaled correctly, based on the CBCT image. Without the
gradient term, the orientation may be physically based, but the magnitude of
the update may be wrong as the CBCT and 4DCT reconstructions have di↵erent
intensity-ranges within the images. Alternative ways to account for the di↵erent
intensity ranges between the 4DCT and CBCT reconstructions are to be left for
future development.
Note that since the constrained non-rigid and fully deformable motion models
have now been related, it would be possible to first use the constrained non-
rigid approach as the starting estimate of the fully deformable approach. This
may greatly reduce the number of iterations (compared to assuming zero motion)
required, as well as improving the estimate in low contrast regions.
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Chapter 7
Contributions
For this thesis, contributions have been made in the development of a variety
of methods of building motion models from a CBCT scan, for the purposes of
guiding tracked RT treatment.
In Chapter 3, I devised the CBCT-specific underpinnings of an iterative
method to build a motion model of the tumour region only. The tumour region
is the most critical region to monitor during RT treatment, and the markerless
method presented can be used with the standard CBCT scan and protocol used
during RT treatment. The only additional requirement is acquiring a synchro-
nised surrogate signal, which can be further monitored to drive tracked treatment.
The cost function is of a positive definite quadratic form, with a global minimum
which can be found quickly. The method does not require markers, avoiding
the risks associated with their implantation. Scans acquired at planning are not
needed by the method, so can account for changes of tumour appearance and
motion over each fraction of treatment. The motion model is used to perform a
motion compensated reconstruction (MCR), which utilises all the projection data
so does not su↵er from the artefacts seen in 4D-CBCT. The MCR can then be
105
animated using the motion model to evaluate tumour motion during the CBCT.
CBCT scans are routinely acquired immediately prior to and in the middle of
each fraction, ensuring the motion model built is appropriate for each fraction of
treatment and can be assessed mid-treatment for accuracy. As well as evaluation
of tumour motion prior to treatment, real-time surrogate data could be used to
predict tumour position during treatment and so guide gated or tracked treat-
ments. In proton therapy, where motion compensation is even more important
[8], this method could also be of use [15]. Results on a simulated, phantom and
clinical datasets are presented.
In Chapter 4, I extended and generalised this iterative method to a whole-
patient motion model. This new approach can now be used to track the tu-
mour region and OAR, whilst retaining many of the attractive features of the
tumour-only method. A model of this kind is important for delivering tracked
RT treatments, ensuring modifications to the beam do not over-expose the OAR.
A surrogate-driven motion model is used to overcome the di culties associated
with real-time imaging of the internal anatomy. Once the model has been built,
only a new surrogate measurement is needed to estimate the patient state. The
surrogate can be monitored easily throughout treatment, avoiding implanting
markers or taking additional scans. The motion model is posed in a way which
exploits the relative strengths of the datasets most often available during RT
treatment: The planning 4DCT and positioning CBCT. The higher quality plan-
ning 4DCT is used to construct what the authors term weighting arrays. The
weighting arrays are essentially deformation fields within the model, which de-
scribe how the anatomy of the patient could vary with the surrogate signals. The
motion model parameters (after being weighted by the weighting arrays) are then
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fitted to the CBCT, which can account for the inter-fraction variation that occurs
between planning and the day of treatment. The motion model parameters are
global in nature (same over the whole volume). This means the number of model
parameters to fit on the day of treatment is low and they can be quickly found.
The motion model is also robust against many of the previously mentioned prob-
lems a↵ecting CBCT. In addition, delineations from planning can be imported
onto the model, providing tumour and OAR boundaries based on those used to
construct the plan. Results on simulated and clinical datasets are presented.
In some cases, it is advantageous to be able to build a motion model completely
from the CBCT scan. In Chapter 5, I presented a novel approach to achieve this.
As well as being used to completely build the motion model from scratch, this
method can also be used to augment the full patient motion model presented
in Chapter 4. This is especially useful where large inter-fraction variations are
present. These could include weight loss, tumour shrinkage or lung region col-
lapse. Although this latter approach is left to future work, the connection between
the motion models used for Chapters 4 and 5 are described to highlight the con-
nections between the two approaches and how they could compliment each other.
By extending an optical-flow-based approach, voxel-wise updates to the motion
model are determined. A modified CBCT reconstruction is proposed, which mea-
sures the di↵erences between the actual and current estimate of the motion, and
how these di↵erences correlate to the surrogate signals of the motion model. From
these reconstructions, the current estimate of the motion can be updated via an
analytical expression. Results on a simulated case are presented.
Via the work presented in this thesis, it is ultimately intended for a variety
of options to be made available to monitor patient respiratory motion, during
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tracked RT treatment. Whether it be simply determining tumour motion or a
whole patient motion model, the methods presented should satisfy a wide range
of situations. With further development, it is hoped that these methods can form
a key component of tracked RT treatments, to ultimately improve treatment
outcomes for lung cancer patients.
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Appendix A
Derivation of cost function
The cost functions used for the tumour-only (3.2) and constrained non-rigid (4.2)
motion models are derived from algebraic expansion and simplification. Here the
cost functions are derived in full, starting with the constrained non-rigid motion
model from which the simplified form of the tumour-only motion model can be
found. The cost function can be written:
 µ = argmin
 µ
"X
n
X
pixels
(Rn   Pn (rVn ·  Fn))2
#
, (A.1)
where  Fn can take the constrained non-rigid motion model:
 Fn (x) = snD1 (x)    µ1 + s˙nD2 (x)    µ2. (A.2)
Substituting (4.4) into (4.3) and algebraically expanding, the right hand side of
the cost function (in the square brackets) now becomes:
(A.3)
X
n
X
pixels
(Rn   Pn (rVn ·  Fn))2 =
X
n
X
pixels
(Rn   Pn (rxVn xFn)
  Pn (ryVn yFn)  Pn (rzVn zFn))2 ,
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where the subscripts of r and   indicate the relevant directional component.
Further expanding the squared bracket:
(A.4)
X
n
X
pixels
(RnRn  RnPn (rxVn xFn) RnPn (ryVn yFn)
 RnPn (rzVn zFn)  Pn (rxVn xFn)Rn
  . . .+ Pn (rzVn zFn)Pn (rzVn zFn)) ,
and writing the full form of each directional component of  Fn:
(A.5)
X
n
X
pixels
(RnRn  RnPn (rxVn   (snD1,x µ1,x + s˙nD2,x µ2,x))
 RnPn (ryVn   (snD1,y µ1,y + s˙nD2,y µ2,y))
 RnPn (rzVn   (snD1,z µ1,z + s˙nD2,z µ2,z))
  Pn (rxVn   (snD1,x µ1,x + s˙nD2,x µ2,x))Rn   . . .
+ Pn (rzVn   (snD1,z µ1,z + s˙nD2,z µ2,z))Pn (rzVn
  (snD1,z µ1,z + s˙nD2,z µ2,z))) ,
where because the patient volume has been discretised into voxels, the   symbol
(Hadamard product) is used to indicate a voxel-wise multiplication within the
volume, prior to forward projection. The   product is unneccesary between the
weighting array and motion model updates when only one direction-composition
is chosen as is the case here. Further expanding the terms, due to the projection
operator being additive:
(A.6)
X
n
X
pixels
(RnRn  RnPn (rxVn   (snD1,x µ1,x))
 RnPn (rxVn   (s˙nD2,x µ2,x)) RnPn (ryVn   (snD1,y µ1,y))
 RnPn (ryVn   (s˙nD2,y µ2,y)) RnPn (rzVn   (snD1,z µ1,z))
 RnPn (rzVn   (s˙nD2,z µ2,z))  Pn (rxVn   (snD1,x µ1,x))Rn
  Pn (rxVn   (s˙nD2,x µ2,x))Rn   . . .
+ Pn (rzVn   (snD1,z µ1,z))Pn (rzVn   (snD1,z µ1,z))
+ 2Pn (rzVn   (snD1,z µ1,z))Pn (rzVn   (s˙nD2,z µ2,z))
+ Pn (rzVn   (s˙nD2,z µ2,z))Pn (rzVn   (s˙nD2,z µ2,z))) .
 µi,j; i = 1, 2, j = x, y, z is the same across all voxels for all values of n, hence
can be taken outside the Hadamard product, projection operator and sums over
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pixel and n. Similarly for sn, with the exception that it is dependent on n, so
can be taken outside the Hadamard product and projection operator (it could
also be taken outside the sum over pixel but due to the low computational cost,
this is not done here for a more appealing final cost function). By reordering the
operations as described, one arrives at the form of the cost function described in
Chapter 4.
µ1, µ2 = argmin
µ1,µ2
"
6X
✓, =0
 ✓  
X
n
X
pixels
C✓C 
#
, (A.7)
where
 0 = 1,
0BBBBBB@
 1
 2
 3
1CCCCCCA = µ1,
0BBBBBB@
 4
 5
 6
1CCCCCCA = µ2. (A.8)
and
C0 = pn   Pn(Vn),
0BBBBBB@
C1
C2
C3
1CCCCCCA =  sn
0BBBBBB@
Pn (rxVn  D1,x)
Pn (ryVn  D1,y)
Pn (rzVn  D1,z)
1CCCCCCA ,
0BBBBBB@
C4
C5
C6
1CCCCCCA =  s˙n
0BBBBBB@
Pn (rxVn  D2,x)
Pn (ryVn  D2,y)
Pn (rzVn  D2,z)
1CCCCCCA .
(A.9)
This form is advantageous as during the CBCT-based fitting (when determining
 ✓) all the other components (
P
n
P
pixelsC✓C ) can be determined at the be-
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ginning of the optimisation. If this were not done, projections of a continually
varying volume would need to be recalculated and summed at each trial value of
the motion model parameters, greatly increasing optimisation time.
The steps can be taken with the tumour-only motion model equation to ob-
tain the associated cost function. Alternatively, one can achieve the same result
by slightly modifying the constrained non-rigid cost function. Simply set the
weighting arrays to 1 within the tumour region (and zero outside). During the
calculation of the cost function, the tumour enhanced projections will be auto-
matically calculated within the cost function, hence the tumour enhancement
method does not need to be applied with this modified approach.
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